Facility that provides controlled conditions in which scientific or technological research, experiments, and measurement may be performed.
POPULARITY
Categories
287 episodes with Laboratory
346 episodes with Laboratory
253 episodes with Laboratory
185 episodes with Laboratory
33 episodes with Laboratory
37 episodes with Laboratory
64 episodes with Laboratory
38 episodes with Laboratory
33 episodes with Laboratory
29 episodes with Laboratory
22 episodes with Laboratory
64 episodes with Laboratory
43 episodes with Laboratory
51 episodes with Laboratory
55 episodes with Laboratory
30 episodes with Laboratory
14 episodes with Laboratory
23 episodes with Laboratory
12 episodes with Laboratory
16 episodes with Laboratory
30 episodes with Laboratory
28 episodes with Laboratory
34 episodes with Laboratory
16 episodes with Laboratory
13 episodes with Laboratory
14 episodes with Laboratory
13 episodes with Laboratory
12 episodes with Laboratory
11 episodes with Laboratory
6 episodes with Laboratory
16 episodes with Laboratory
4 episodes with Laboratory
14 episodes with Laboratory
13 episodes with Laboratory
15 episodes with Laboratory
9 episodes with Laboratory
6 episodes with Laboratory
4 episodes with Laboratory
7 episodes with Laboratory
4 episodes with Laboratory
10 episodes with Laboratory
10 episodes with Laboratory
11 episodes with Laboratory
7 episodes with Laboratory
12 episodes with Laboratory
6 episodes with Laboratory
![VERITAS w/ Mel Fabregas | [Non-Member Feed] | Subscribe at http://www.VeritasRadio.com/subscribe.html to listen to all parts.](https://ivyfm.s3.amazonaws.com/i320/347516.jpg)
7 episodes with Laboratory
5 episodes with Laboratory
8 episodes with Laboratory
9 episodes with Laboratory
14 episodes with Laboratory
7 episodes with Laboratory
5 episodes with Laboratory
6 episodes with Laboratory
7 episodes with Laboratory
7 episodes with Laboratory
16 episodes with Laboratory
4 episodes with Laboratory
9 episodes with Laboratory
7 episodes with Laboratory
6 episodes with Laboratory
5 episodes with Laboratory
6 episodes with Laboratory
4 episodes with Laboratory
6 episodes with Laboratory
3 episodes with Laboratory
4 episodes with Laboratory
4 episodes with Laboratory
3 episodes with Laboratory
14 episodes with Laboratory
4 episodes with Laboratory
12 episodes with Laboratory
4 episodes with Laboratory
6 episodes with Laboratory
4 episodes with Laboratory
6 episodes with Laboratory
3 episodes with Laboratory
13 episodes with Laboratory
5 episodes with Laboratory
9 episodes with Laboratory
3 episodes with Laboratory
4 episodes with Laboratory
6 episodes with Laboratory
4 episodes with Laboratory
2 episodes with Laboratory
5 episodes with Laboratory
9 episodes with Laboratory
9 episodes with Laboratory
3 episodes with Laboratory
4 episodes with Laboratory
5 episodes with Laboratory
4 episodes with Laboratory
4 episodes with Laboratory
4 episodes with Laboratory
2 episodes with Laboratory
3 episodes with Laboratory
2 episodes with Laboratory
3 episodes with Laboratory
6 episodes with Laboratory
6 episodes with Laboratory
7 episodes with Laboratory
5 episodes with Laboratory
2 episodes with Laboratory
5 episodes with Laboratory
2 episodes with Laboratory
9 episodes with Laboratory
4 episodes with Laboratory
3 episodes with Laboratory
Daryn is a clinical professor of psychiatry and behavioral sciences at Stanford, dedicated to advancing trauma-informed mental health care and human rights. He leads the Human Rights in Trauma Mental Health Program, where he works with survivors of genocide, torture, and human rights violations locally and globally. With extensive experience in cross-cultural trauma psychiatry, Daryn consults for international courts and international investigations of war crime advising on complex cases of transitional justice and mental health. He currently serves as a consultant for trauma psychiatry to the United Nations' Investigative Team to Promote Accountability for Crimes Committed by Da'esh/ISIL, for the International Criminal Court, and for Human Rights Watch. He has developed new clinical and educational programs for underserved communities in the Bay Area. Daryn also teaches a course on the psychology of happiness and leads the Stanford Stoked! Laboratory. Send a textSupport the showCan't get enough of the Journey On Podcast & it's guests? Here are two more ways to engage with them. Find exclusive educational content from previous podcast guests which include webinars, course and more: https://courses.warwickschiller.com If you want to meet your favorite podcast guest in person, you can attend our annual Journey On Podcast Summit either in person or via live stream: https://summit.warwickschiller.com Become a Patreon Member today! Get access to podcast bonus segments, ask questions to podcast guests, and even suggest future podcast guests while supporting Warwick: https://www.patreon.com/journeyonpodcastWarwick has over 900 Online Training Videos that are designed to create a relaxed, connected, and skilled equine partner. Start your horse training journey today!https://videos.warwickschiller.com/Check us out on Facebook: https://www.facebook.com/WarwickschillerfanpageWatch hundreds of free Youtube Videos: https://www.youtube.com/warwickschillerFollow us on Instagram: @warwickschiller
Michelle R Campbell, Kornelia Galior. An Overview of Allowable Total Error in the Clinical Laboratory. The Journal of Applied Laboratory Medicine, Volume 11, Issue 2, March 2026, Pages 357–367. https://doi.org/10.1093/jalm/jfaf160
Six years ago, as countries around the world went into COVID lockdowns, the air got cleaner. Factories slowed down, roads emptied and aeroplanes were grounded. As people stayed home, the world burned fewer fossil fuels and so carbon dioxide emissions dropped.But something else was also happening in the atmosphere. Levels of methane, an extremely potent greenhouse gas that warms the planet even faster than CO2, rose faster in 2020 than at any point since records began in the 1980s. And methane levels kept on rising during 2021 and 2022.Ever since, scientists have been trying to piece together what caused this sudden mysterious increase in methane. Now, they think they have the answer – and it was partly due to COVID lockdowns.In this episode, we speak to Philippe Ciais, a researcher at the Laboratory for Environmental and Climate Science at Université Paris-Saclay in France, and one of the authors of a new study in the journal Science about the spike in methane levels, who explains how they solved the mystery.This episode was written and produced by Mend Mariwany and Katie Flood and Gemma Ware was the executive producer. Mixing by Eleanor Brezzi and theme music by Neeta Sarl. Read the full credits for this episode and sign up here for a free daily newsletter from The Conversation.If you like the show, please consider donating to The Conversation, an independent, not-for-profit news organisation.Mentioned in this episode:The Making of an AutocratSearch "The Conversation Weekly" for our new series: The Making of an Autocrat. Is America watching its democracy unravel in real time? In The Making of an Autocrat from The Conversation, six of the world's pre-eminant scholars reveal the recipe for authoritarian rule. From capturing a party, to controlling the military, Donald Trump is borrowing from the playbook of strongmen thoughout history. This is the story of how democracies falter — and what might happen next.
In 1965 Margaret Crane was a young designer creating packaging for a pharmaceutical company when a scientist gave her a tour of the lab. Looking at the long rows of pregnancy tests she thought, well anyone could do that test at home! So she set about designing a prototype for America's first home pregnancy test. While the design of the prototype was simple, convincing the company, the medical community and conservative social leaders that at-home pregnancy testing was safe and necessary was an uphill climb for Crane, who is only now receiving credit for her contributions to the industry. This show first aired in February 2024. Featuring: Margaret Crane - Graphic designer and inventor of the first home pregnancy test Wendy Kline - Dema G. Seelye Chair in the History of Medicine, History Faculty Purdue University Jesse Olszynko-Gryn - Head of the [Laboratory for Oral History and Experimental Media](https://www.mpiwg-berlin.mpg.de/research/projects/laboratory-oral-history-and-experimental-media) at Max Planck Institute for the History of Science Arthur Kover - Emeritus Professor of Marketing, Fordham University Alexandra Lord - Chair, Division of Medicine and Science at the National Museum of American History Making Contact Staff: Host: Amy Gastelum Guest Producer: Anne Noyes Saini Producers: Anita Johnson, Salima Hamirani, Amy Gastelum, and Lucy Kang Executive Director: Jina Chung Editor: Adwoa Gyimah-Brempong Engineer: Jeff Emtman Digital Media Marketing: Lissa Deonorain Music: Podington Bear, Rhythm and Strings Learn More: National Museum of American History https://americanhistory.si.edu/collections/nmah_1803285 A Woman's Right to Know, Pregnancy Testing in 20th Century Britain - https://mitpress.mit.edu/9780262544399/a-womans-right-to-know/ Predictor, by Jennifer Blackmer https://newplayexchange.org/plays/348156/predictor Making Contact is an award-winning, nationally syndicated radio show and podcast featuring narrative storytelling and thought-provoking interviews. We cover the most urgent issues of our time and the people on the ground building a more just world.
Season FIVE Episode NINE of the Your Story Our Fight® podcast welcomes Ruth Wilson. Ruth Wilson is a scientist and laboratory leader with a background in immunology and microbiology, as well as data science. Diagnosed with lupus as a young adult, she became a passionate advocate and transformed her personal challenges into a mission to amplify the patient voice and drive more compassionate, patient-centered research. Through her advocacy, mentorship, and community leadership, Ruth works to ensure that science never loses sight of the human stories behind the data. She is deeply committed to advancing awareness, improving outcomes, and bringing hope to others navigating life with lupus.
Hey Voices from the Bench community! Jessica Love here, sending a shoutout from Utah! If you're passionate about creating natural, beautiful smiles—but want to simplify your workflow without sacrificing aesthetics—this is for you. I'm honored to be part of Ivoclar's development team introducing a powerful new stain and glaze system featuring Structure Paste, IPS e.max Ceram Art. Create stunning depth and lifelike color in as little as one firing. Let's continue to innovate, simplify, and create meaningful change—one smile at a time. Elvis actually made it down to the exhibition halls this year — and hyperDENT from FOLLOW-ME! Technology was everywhere. Booth after booth, people were talking milling strategies, templates, and workflows. It felt like a full-on CAM takeover. Their Milling Roadmap scavenger hunt had attendees bouncing between Axsys, Imagine, D.O.F., and Roland collecting stamps like responsible adults… Responsible adults chasing a bright orange folding electric hyperDENT scooter. That's what we love about the FOLLOW-ME! team — world-class CAM engineers talking microns and validation protocols one minute, then ripping around Lab Day the next. Serious about precision. Not too serious about themselves. Big shoutout for bringing the brains — and the electric horsepower. Come see and talk to Elvis and Barb at all these amazing shows in 2026* Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 At the 100-year celebration of the Cal-Lab Association, Elvis checks in with past chair Jeff Stronk after the first full day of the meeting to see how things are going. With Barb stepping into the chair role and kicking things off in style, Jeff talks about the incredible energy in the room, the rise in attendance, and the surprising number of first-time lab owners showing up. From powerful panel discussions filled with unforgettable one-liners to honest conversations about succession planning, leadership, and the realities of running a lab, day one proves why this meeting has survived for a century. Unlike traditional trade shows packed with sales pitches, Cal-Lab keeps the focus on real lab owners sharing real experiences, giving attendees practical insights they can take back to their businesses. After moving over to the Ivoclar Ballroom at LMT Lab Day Chicago, the conversation shifts to the future of the industry with April Newell, a former dental hygienist who strategically worked her way into the world of additive manufacturing at Nota3D. Now selling advanced resin and metal 3D printing systems to dental labs, April breaks down how 3D printing evolved from simple model production to full frameworks and implant bars. She explains the realities of metal printing, the technology behind lasers and powder systems, and why labs that invest in metal printing tend to grow faster than they expect. Her perspective highlights just how quickly digital manufacturing is changing the lab landscape—and how dentistry continues to pull people into its orbit for life. Finally, Elvis talks with Joey Hunter, a veteran technician with nearly 30 years in the industry and a true removable specialist. Joey shares how she answered a newspaper ad looking for a “starving artist” back in the 90s and ended up building a lifelong career in dental technology. From mastering every step of removable fabrication to adapting after losing her hearing during her career, Joey's story highlights both the artistry and resilience behind the craft. Now working at Renstrom Dental Studio, she reflects on seeing LMT Lab Day Chicago 2026 for the first time and being amazed by how far the industry has come. Her experience reminds everyone that while technology continues to evolve, the hands-on knowledge and artistry of technicians remain at the heart of dentistry. Hey, listeners—ever wonder what Elvis is doing when he's not recording Voices from the Bench? He's a client rep for Derby Dental Laboratory, out in the field every day doing chairside visits and building relationships. His job is simple—keep doctors happy and keep them coming back. And he couldn't do it without iCortica. Right from his phone, Elvis can see sales, remake rates, account notes, risks, and cross-sell opportunities—even before he walks through the door. No spreadsheets. No surprises. Just the info he needs to grow accounts. Stop digging for data and start taking action. Head to icortica.com and schedule your demo today. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the Women in Dentistry Lunch, celebrating career growth, wellbeing, and the real stories shaping our profession. And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off.Special Guests: April Newell, Jeff Stronk, and Joey Hunter.
Mohit KheraBaylor College of Medicine, United States of AmericaDr. Khera earned his undergraduate degree at Vanderbilt University. He subsequently earned his MBA and his MPH from Boston University. He received his Medical Degree from The University of Texas Medical School and completed his Urology residency training in the Scott Department of Urology at Baylor College of Medicine. He went on to complete a one-year fellowship in Male Reproductive Medicine and Surgery at Baylor. Currently he is a Professor of Urology at Baylor College of Medicine, and he holds the F. Brantley Scott Chair in Urology. Dr. Khera also serves as the Director of the Laboratory for Andrology Research, the Medical Director of the Scott Department of Urology, and the Associate ProgramDirector of the Baylor Infertility and Sexual Medicine Fellowship Program. He is also the past President of the Sexual Medicine Society of North America.Dr. Mohit Khera's website: https://drmohitkhera.com/Support the show
In this episode, I sit down with the legendary Nikki Myers—MBA, Somatic Experiencing® Practitioner, and founder of Y12SR: The Yoga of 12-Step Recovery. Nikki has spent decades at the crossroads of addiction recovery and somatic wisdom, teaching us that while the 12-Step meetings provide the "cognitive map," the yoga mat provides the "somatic laboratory" for true healing.We dive deep into the soul-level work of recovery, discussing how to come home to a body that has been through the fire. If you have ever felt like your body was an unsafe place to be, or if you've struggled to find the "space" between a trigger and a response, this conversation is for you.In this episode, we explore:The Birth of Y12SR: Why the "top-down" approach of 12-step programs needs the "bottom-up" wisdom of yoga to facilitate sustainable recovery.The Issues in the Tissues: A deep dive into how trauma, heartbreak, and addiction literally manifest in our fascia, our breath, and our posture.From Escaping to Befriending: How to stop numbing the body and start trusting it again, even when it feels full of cravings or anxiety.The Laboratory of the Mat: Using a yoga pose to practice staying present when things get uncomfortable, building the "resilience muscle" needed for daily life.Holding Space for the Healer: Nikki shares her personal practice for maintaining wholeness while holding space for thousands in their darkest moments.About Nikki MyersNikki Myers is an accomplished teacher, practitioner, and speaker who has been featured in The New York Times, Yoga Journal, and Huffington Post. As the founder of Y12SR, she has trained thousands of leaders across the globe to integrate the cognitive tools of 12-step programs with the somatic tools of yoga. Her work is a testament to the fact that recovery is not just a mental shift, but a full-body homecoming.Connect with Nikki:Website: y12sr.comInstagram: @nikkimyersy12srSupport the showConnect with Inner Peace Yoga Therapy Email us: info@innerpeaceyogatherapy.com Website Instagram Facebook
Six women. Five continents. Decades of experience spanning wildlife veterinary practice, disease research, government policy, and international conservation. Recorded for 2026 International Women's Day, this episode brings together an extraordinary panel to celebrate women in wildlife health, their journeys, their achievements, and their honest reflections on working in a field that hasn't always made space for them.From Taiwan to Kenya, Wyoming to Brazil, Indonesia to Germany, our guests share what drew them to wildlife health and what they've had to navigate along the way, the subtle daily realities of male-dominated spaces, alongside the genuine optimism that comes from seeing more women enter the field and rise into leadership. Warm, funny, and deeply human, this is the kind of conversation that reminds you why community matters in this work.Watch this episode as a video podcast on our Youtube channel here. Learn more about our panelists:Dr. AiMei Chang, wildlife veterinarian and academic at the National Pingtung University of Science and Technology in Taiwan, and Secretary of the WDA Asia-Pacific sectionDr. Sharon Mulindi, Senior Veterinary Officer at Kenya Wildlife Service and a Masters student of Conservation Medicine at the University of Edinburgh, and Vice Chair of the WDA Africa and Middle East sectionDr. Aricia Duarte-Benvenuto, veterinarian and postdoctoral researcher at the Laboratory of Wildlife Comparative Pathology at the University of São Paulo in BrazilDr. Kim Gruetzmacher, Wildlife and Conservation Veterinarian, working for the German Federal Agency for Nature Conservation as Head of the Division for International Nature ConservationDr. Samantha Allen, Supervisor of the Veterinary Service unit (Wyoming Game and Fish Department), State Wildlife Veterinarian for Wyoming, and President of the American Association of Wildlife VeterinariansDr. Fransiska Sulistyo, wildlife veterinarian and consultant specialising in orangutan conservation and rehabilitation in Indonesia, and a PhD student at Adelaide University.We'd love to hear from you ... share your thoughts, feedback and ideas.
In this episode, Christopher Burks, Vice President of Laboratory and Support Services at Brown University Health, discusses integrating newly acquired hospitals, aligning revenue and operations, and building the laboratory bandwidth needed to support ambulatory growth and long term system expansion.
In this episode, Niall speaks with Dr. Kevin Tracey, a neurosurgeon, inventor, researcher, and author of “The Great Nerve”, who leads the Feinstein Institutes for Medical Research. Dr. Tracey's research has shown how the vagus nerve connects the brain and immune system, controlling inflammation in the body. His work has led to FDA-approved treatments for rheumatoid arthritis and may help with depression, PTSD, and other inflammatory conditions. In this conversation, they explore: — How the vagus nerve acts as a biological “brake” for inflammation — The potential of bioelectronic medicine to treat inflammatory diseases without immunosuppression — The story of Kelly Owens, whose life was transformed by vagus nerve stimulation — Why inflammation may underlie many modern diseases — The future of precision medicine using targeted nerve stimulation And more. You can learn more about Dr. Tracey's work through his book “The Great Nerve”, or at X at x.com/KevinJTraceyMD. — Kevin J. Tracey is president and CEO of, and the Karches Family Distinguished Chair in Medical Research at the Feinstein Institutes for Medical Research; professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; and Executive Vice President, Research, at Northwell Health. A leader in the scientific fields of inflammation and bioelectronic medicine, his contributions include discovery and molecular mapping of neural circuits controlling immunity. Dr. Tracey received his BS in chemistry, summa cum laude, Phi Beta Kappa, from Boston College in 1979, and his MD from Boston University in 1983. He trained in neurosurgery from 1983 to 1992 at the New York Hospital-Cornell University Medical Center and was a guest investigator at the Rockefeller University before moving in 1992 to the Feinstein Institutes. There he directs the Laboratory of Biomedical Science and was appointed president and CEO in 2005. An inventor of more than 120 United States patents and author of more than 400 scientific publications, he cofounded the Global Sepsis Alliance, a non-profit organization supporting the efforts of more than 1 million sepsis caregivers in over 70 countries. Dr. Tracey is the author of Fatal Sequence (Dana Press) and delivers lectures nationally and internationally on inflammation, sepsis, the neuroscience of immunity, and bioelectronic medicine. --- Interview Link: — Dr. Tracey's X: http://x.com/KevinJTraceyMD
https://teachhoops.com/ Winning in the summer is not measured by your record in a July tournament; it is measured by the developmental gap you close before October. The summer months are the "Laboratory of Growth" where you have the freedom to experiment, fail, and rebuild without the immediate pressure of a conference standings table. To "win" the summer, you must shift your focus from "Outcome-Based" coaching (winning the game) to "Process-Based" coaching (winning the rep). This means using your summer league games as high-speed practice sessions. If your team struggled with "Ball-Screen Coverage" in February, your summer "win" is successfully executing that coverage 20 times in a weekend, regardless of what the scoreboard says at the final buzzer. A key pillar of summer success is "Strategic Exposure vs. Rep Density." There is a common trap in youth basketball where teams travel across the country to play five games in three days, only to spend more time in a van than in a gym. To truly "win," you must balance your "Exposure" (AAU/Tournaments) with "Acquisition" (Skill Work). Ideally, your summer should follow a 2:1 Ratio: for every hour spent playing in a game, you should spend two hours in purposeful, high-intensity skill development. Use the summer to "deconstruct" a player's shot or "re-wire" their defensive footwork. When the game-to-practice ratio is out of balance, you aren't building players; you are just "managing fatigue." Finally, winning in the summer requires "Cultural Installation." This is the time to "onboard" your incoming freshmen and establish your "Program Non-Negotiables." Use your summer sessions to build "Trust Equity" through team-building rituals and "Small-Sided Games" that foster communication. Utilize your TeachHoops member calls to "audit" your summer curriculum: are you just "playing," or are you "installing"? By the time you reach the August "Dead Period," your players should have a clear understanding of your offensive spacing and your defensive "Shell" principles. If your team enters the fall with a higher Basketball IQ and a more resilient "Work Ethic," you have already won the most important championship of the year. Summer basketball, basketball coaching, player development, AAU basketball, basketball IQ, coach development, team culture, high school basketball, youth basketball, basketball strategy, skill acquisition, basketball conditioning, off-season training, basketball success, athletic leadership, program building, coach unplugged, teach hoops, basketball mentorship, summer league, mental toughness, basketball drills. SEO Keywords Learn more about your ad choices. Visit podcastchoices.com/adchoices
This week on Blamo!, I'm joined by Greg Jackson, founder of Greg Laboratory. Greg's path runs from growing up in D.C. to Detroit, from BAPE and Dunks to a serious run at Nike, where he learned firsthand what it takes to build product at the highest level. We talk about what he took from Nike (and why he left), launching Greg Laboratory, making things in New York, the art of refinement, and why a pocket might matter more than you think. There's Jay-Z, bespoke tailoring, Mexico, and the strange tension of making clothes that might be… too nice to wear. https://greglaboratory.com/ * Sponsored by Bezel - the trusted marketplace for buying and selling your next luxury watch Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Hey Voices from the Bench community! Jessica Love here, sending a shoutout from Utah! If you're passionate about creating natural, beautiful smiles—but want to simplify your workflow without sacrificing aesthetics—this is for you. I'm honored to be part of Ivoclar's development team introducing a powerful new stain and glaze system featuring Structure Paste, IPS e.max Ceram Art. Create stunning depth and lifelike color in as little as one firing. Let's continue to innovate, simplify, and create meaningful change—one smile at a time. Elvis actually made it down to the exhibition halls this year — and hyperDENT from FOLLOW-ME! Technology was everywhere. Booth after booth, people were talking milling strategies, templates, and workflows. It felt like a full-on CAM takeover. Their Milling Roadmap scavenger hunt had attendees bouncing between Axsys, Imagine, D.O.F., and Roland collecting stamps like responsible adults… Responsible adults chasing a bright orange folding electric hyperDENT scooter. That's what we love about the FOLLOW-ME! team — world-class CAM engineers talking microns and validation protocols one minute, then ripping around Lab Day the next. Serious about precision. Not too serious about themselves. Big shoutout for bringing the brains — and the electric horsepower. Come see and talk to Elvis and Barb at all these amazing shows in 2026* Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week, we sit down with Richard Rosas Sr — artist, entrepreneur, removable specialist, and the man behind one of the most creative workflows we've heard in a long time. Richard's journey starts in Lancaster, Pennsylvania, where he grew up moving between nine schools, discovered a gift for fine art, and even earned a scholarship to Tyler School of Art and Architecture — which he turned down out of fear of becoming a starving artist. After a detour into computer programming, granite engraving, and even opening a salsa dance studio with his mom (yes, there's a South Beach nightclub moment that changed everything), Richard eventually answered a tiny newspaper ad asking, “Are you an artist?” That question led him into a dental laboratory and launched a career that would blend creativity, discipline, faith, and serious removable skills. Under intense mentorship and PTC-style training, Richard sharpened his craft in removables, eventually managing a department and earning enough respect that doctors specifically requested him chairside. One large account even pulled all their cases after Richard pushed back on unrealistic deadlines — only to return weeks later with deeper respect and loyalty. That experience shaped his philosophy: honesty, communication, and quality always win long term. His path then led him to ClearChoice Dental Implant Centers, where performing four to six arches a day gave him next-level surgical and prosthetic experience. It was there that the real lightbulb went off — immediate impression evaluation, real-time patient interaction, faster turnaround, and true collaboration between surgeon, prosthodontist, and technician completely changed his view of what was possible. Now Richard has taken that high-efficiency, patient-centered model and built something entirely his own: a boutique removable lab with a fully functional, patent-pending mobile on-site dental laboratory inside a Mercedes Sprinter van. By bringing the lab directly to private practices, he combines multiple traditional appointments into streamlined visits, delivers final dentures in as little as two weeks, processes chairside in the parking lot, and markets not only to dentists but directly to patients. His mission isn't just to make dentures faster — it's to elevate the technician's role, strengthen patient connection, and show that removables can be both efficient and beautiful. Through his new YouTube channel, Mastering Removables, he's beginning to share that knowledge with others who want to rethink what a lab can be. Hey, listeners—ever wonder what Elvis is doing when he's not recording Voices from the Bench? He's a client rep for Derby Dental Laboratory, out in the field every day doing chairside visits and building relationships. His job is simple—keep doctors happy and keep them coming back. And he couldn't do it without iCortica. Right from his phone, Elvis can see sales, remake rates, account notes, risks, and cross-sell opportunities—even before he walks through the door. No spreadsheets. No surprises. Just the info he needs to grow accounts. Stop digging for data and start taking action. Head to icortica.com and schedule your demo today. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the FIRST 5k run on the coast! And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off.Special Guest: Richard Rosas Sr.
Send a textDr. Allison Reiss, MD is an internal medicine physician, molecular biologist, and educator whose career sits at the critical intersection of inflammation, cardiometabolic disorders, and neurodegeneration.Dr. Reiss serves as Associate Professor of Medicine and Head of the Inflammation Laboratory at the NYU Grossman Long Island School of Medicine ( https://medli.nyu.edu/faculty/allison-b-reiss ). She is also a Member of the Medical, Scientific & Memory Screening Advisory Board of the Alzheimer's Foundation of America.For more than 25 years, Dr. Reiss' research has explored how immune and metabolic dysfunction contribute to neuronal loss in Alzheimer's disease and accelerated atherosclerosis in conditions such as lupus, rheumatoid arthritis, and diabetes — helping illuminate the biological links between brain health, vascular disease, and aging.Clinically trained and board-certified in internal medicine, Dr. Reiss brings a rare translational perspective, connecting bedside observations with molecular mechanisms. Beyond the lab, she is a dedicated mentor and educator, directing translational research training for medical students and actively inspiring the next generation of clinician-scientists.Dr. Reiss' work has been recognized by organizations including the American Heart Association and the Alzheimer's Foundation of America, and she serves in editorial leadership roles across several journals focused on cardiovascular disease, aging, and neurodegeneration.On this episode, we explore the evolving science of neuroinflammation, the metabolic roots of Alzheimer's disease, and how understanding immune-brain-vascular crosstalk may unlock entirely new therapeutic strategies for aging populations.#AlzheimersDisease #Neuroinflammation #BrainHealth#DementiaPrevention #MetabolicHealth #VascularHealth#LongevityScience #Neurodegeneration #MedicalResearch #PhysicianScientistSupport the show
Keith Poulsen, professor at the University of Wisconsin and director of the Wisconsin Veterinary Diagnostic Laboratory, provides an update on the status of highly pathogenic avian influenza (H5N1), as pertains to dairy cattle, poultry, wildlife—and humans. Are we making progress in biosecurity in the dairy industry? Dairy may be decades behind, but keep in mind: “Cows are like walking tanks.” Keeping boots and clothes clean is essential to contain viral spread. Vaccines are often not a viable solution, given trade, economics and political realities. What forces are most impacting the affordability of eggs, beef, and other items? Impacting access to rural workforces, especially migrants? What have been the implications of major recent disruptions at USDA, CDC and FDA?
Part of "Luminaries of Science" series The talk describes how research using the fruit fly Drosophila revealed the make-up of the circadian clock. The first clock gene to be detected in any organism, named “period”, was physically isolated by Young in 1984 and screens in his laboratory subsequently identified five additional genes that are each essential for production of circadian rhythms. Interactions among these genes, and their proteins, contribute to a network of molecular oscillations within single cells throughout the body and allow circadian rhythms to align with environmental day/night cycles. Most of the clock genes discovered by Young and his colleagues in Drosophila are also central to the circadian pathways of humans where they promote rhythmic expression of roughly half our genes. Speaker Michael Young, Richard and Jeanne Fisher Professor and Head of the Laboratory of Genetics, The Rockefeller University Organized by Claude Desplan, Silver Professor of Biology and Neuroscience, Department of Biology, NYU
Neurologic complications of hematologic disorders are frequently encountered in clinical practice and can involve both the central and peripheral nervous systems. Early recognition and appropriate management in collaboration with a hematologist are essential to reduce morbidity and mortality. In this episode, Kait Nevel, MD, speaks with Lauren Patrick, MD, and Mark Terrelonge, MD, MPH, authors of the article "Neurologic Complications of Hematologic Disorders" in the Continuum® February 2026 Neurology of Systemic Disease issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Patrick is an assistant professor of neurology at the University of California, San Francisco, in San Francisco, California. Dr. Terrelonge is an associate professor of neurology at the University of California, San Francisco, in San Francisco, California. Additional Resources Read the article: Neurologic Complications of Hematologic Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Full episode transcript available here Dr Nevel: Thick blood, thin blood. These are terms often used by patients and caregivers to describe some of the hematologic disorders that can lead to neurological diseases such as stroke. So, when should we consider a hematologic disorder as a potential cause for neurological conditions, such as stroke or neuropathy. Today I have the opportunity to interview Drs Lauren Patrick and Mark Terrelonge to learn more about neurologic complications of hematologic disorders in their recent article in Continuum. Dr Jones: This is Dr Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kate Nevel. Today I'm interviewing Drs Lauren Patrick and Mark Terrelonge about their article on neurologic complications of hematologic disorders. This article appears in the February 2026 Continuum issue on neurology of systemic disease. Welcome to the podcast, and please introduce yourself to the audience. Dr Patrick: Thank you for having us. We're both thrilled to be here. I'm Lauren Patrick, a vascular neurologist and assistant professor at the University of California, San Francisco, and program director for the Vascular Neurology Fellowship here. Dr Terrelonge: And I'm Mark Terrelonge, I'm an associate professor of neurology and neuromuscular medicine here at UCSF and one of the associate program directors for the adult neurology residency. Nice to meet you. Dr Nevel: Nice to meet you both. Really looking forward to getting into your article and learning more. So, to kind of kick us off, I always like to ask what do you think is the most important takeaway from your article for the practicing neurologist? And maybe since there are two of you and I suspect you covered slightly different aspects of this article, maybe you could give us two most important takeaways. Dr Patrick: Sure. I think the biggest takeaway is to keep hematologic disorders on the differential when evaluating patients with neurologic symptoms. Conditions like sickle cell disease, myeloproliferative neoplasms, or plasma cell dyscrasias and paraproteinemia can cause strokes or peripheral neuropathies, and many have specific and targetable treatments. The early recognition and collaboration with our hematology colleagues can truly change patient outcomes, whether that's by initiating cytoreductive therapy, managing thrombocytopenia, or optimizing antithrombotic therapy. Dr Nevel: Great. So, this is a really big and diverse topic. As always, I'm going to urge our listeners to read the article because there is a lot of really good stuff in your article that we just don't have time to get into during this interview today. But you cover a lot of different hematological disorders and how they can cause neurological complications. One of the major neurological complications of hematological disorders is cerebral vascular events. So, I'm hoping, Warren, that you can walk us through a little bit. When should we consider workup of potential hematologic disorder as a cause when we see a patient with ischemic stroke, because certainly not all patients with ischemic stroke should be getting a broad hematological disorder work up. So how can we kind of identify early on that there might be something else at play? Dr Patrick: Absolutely, great question. So, in many cases, the underlying hematologic disorder is already known, such as sickle cell disease or polycythemia vera. But sometimes stroke is the initial presentation or manifestation of the disease. So red flags can include young age, recurrent cryptogenic strokes or thrombosis, and unusual locations like the cerebral venous system. Laboratory clues such as unexplained erythrocytosis, thrombocytosis, thrombocytopenia, or hemolytic anemia should raise suspicion for an occult hematologic disorder. In the setting of acute illness, immune-mediated or heparin-induced thrombocytopenia or thrombotic microangiopathies should be suspected in patients that have hemorrhagic and or thrombotic complications, particularly when relevant lab disturbances are present. Acquired thrombophilia such as anti-phospholipid antibody syndrome should be considered in young patients with autoimmune disease, prior venous or arterial thrombotic complications, or pregnancy morbidity. Now, these are rare causes overall, but they're important to catch because the management can differ dramatically from our typical stroke care. Dr Nevel: Great. And what are some of the most common inherited or acquired thrombophilias and when should we be sending these labs? Dr Patrick: The hematologic causes really account for small minority of arterial strokes approximately one to two percent, but among those, sickle cell disease, anti-phospholipid antibody syndrome and the myeloproliferative neoplasms are the most common. Timing of testing is key. So, the genetic thrombophilia panels can be drawn at presentation, but lab values such as protein C, protein S, and antithrombin levels may be falsely low during acute thrombosis, so they're often repeated weeks later. Similarly, for anti-phospholipid antibody testing that should be done at presentation and when positive, confirmed at twelve weeks, since transient positivity can occur with affections or acute events. So, in patients that are already anticoagulated for anti-phospholipid antibody syndrome, testing becomes particularly tricky, especially with lupus anticoagulant assays. Some results need to be interpreted carefully or repeated when feasible. The main message is to collaborate early with our hematology colleagues to guide the timing and interpretation of these studies. Dr Nevel: Yeah, wonderful. Thank you. I'll ask some similar questions about neuropathy. So when should we consider an underlying hematologic disorder as being the cause for someone's neuropathy? Dr Terrelonge: So, luckily for a neurologist, then serum protein electrophoresis or an SPEP is already a part of the first pass evaluation for even the most common neuropathies we see, technically already considered every time we do an evaluation. However, we do know that most neuropathies progress very slowly and don't really lead to significant limitations in patient activities of daily living. And for those, the initial workup step, you may not need to do any additional search for any hematologic diseases after that first step. Within patients who start to have more unusual features with their neuropathy, including a rapid progression, early proximal weakness, significant and extremely painful neuropathies, significant ataxia, or new tremor or anything that's kind of outside of the garden variety neuropathy, then you should start to think about a hematologic cause. Additionally, if a patient already has a known hematologic malignancy or process before their neuropathy, there should be some form of assessment to see through exam or electrodiagnostically if the two are correlated. I do have to add one caveat, though, and that's just because someone has a hematologic malignancy or a paraprotein seen in their blood, their neuropathy and the neurologic syndrome don't necessarily have to be causally related. So, we have to do some additional testing to determine if the patient's presentation of the paraprotein are actually linked. Dr Nevel: Can you walk us through a little bit how we determine if they're associated or just coincidental? Dr Terrelonge: Yeah. So, for some of the proteins, there's a specific phenotype that will come with the specific protein. For example, an anti MAG proteinopathies or MAG standing for a myelin associated glycoprotein, it usually leads to a distal sensor and motor polyneuropathy where the most distal portions of nerves are affected. So, in that case, people might notice that they have numbness and weakness in their toes and their fingers, and it doesn't follow that typical length dependent pattern. So, in that case, if you have the anti mag neuropathy and the electrodiagnostic signature of an anti mag neuropathy along with the symptoms, you're more likely to think that the two are related then if not. Dr Nevel: Great. Thank you. And I was hoping you could speak a little bit more about amyloidosis just because I think that that's one that can be really tricky to diagnose. And I see patients, you know, have sometimes more drawn out evaluations or see multiple providers before a diagnosis is reached. So, can you speak a little bit more to how we diagnose amyloidosis in relationship to neuropathy or other neurological conditions and when we should push for more invasive testing like a nerve biopsy? Dr Terrelonge: So, amyloidosis certainly is a tricky diagnosis. I've been tricked by it and I think most of my neuromuscular colleagues have probably been tricked by it at least once. It's a hard diagnosis to make is it usually requires a pretty high index of suspicion, and also requires a tissue diagnosis to cinch. There're some patients who will come in with a prior history of amyloidosis and they're a little bit easier to figure out if the neuropathy is related. Maybe it's started in their heart or their kidney first and then you can just see if the type of amyloid they have usually deposits in nerve, and that may be enough. But if there's any diagnostic uncertainty, you could go forward with tissue biopsy. But it's patients in which the neuropathy is the first symptom that amyloidosis can be especially tricky to diagnose. It's a primarily light chain disease. So, if you do only an SPEP as a part of your initial neuropathy evaluation, you could miss it. But usually, the patients will have either a severely painful neuropathy, early autonomic dysfunction, or really prominent bilateral carpal tunnel syndrome. So, if they have any of those, usually we'll add in an amyloid workup as a part of that of the rest of the workup, which would include both light chain evaluations to see if there's any increase in Lambda or Kappa light chains and then also biopsy. Biopsy can be of the skin or fat pad first, which have reasonable sensitivity for picking up disease, but they're not necessarily a hundred percent. So if the suspicion remains high in those cases, a nerve biopsy should be considered. And the reason why this is important is that the chemotherapeutic agents that we have now can actually help arrest a lot of these diseases and stop further organ involvement. So, if you think about it, it is important to keep pushing and looking until you find it. Dr Nevel: Thank you so much for that. And a follow up question to that, once patients are started on appropriate therapy, the diagnosis is made, chemotherapy is started, what's the typical clinical course that you see in terms of their neuropathy? Do you ever see improvement or is it arrest of worsening? Dr Terrelonge: Usually for amyloid, there is an arrest of disease, but in some patients, they could have some improvement, not necessarily a dramatic improvement, but some patients could see some reversal of symptoms. That may not necessarily be because nerves injured nerves are regrowing, but because of reorganization of nerves to muscle, they could have some strength increases or at least less pain. Dr Nevel: Yeah, thank you. So, when should we involve a hematologist in aiding in the evaluation of patients we suspect may have an underlying hematological disorder? You guys really outlined very nicely in your article some of the laboratory workup or other workup like you just talked about with amyloidosis. But at what point in that workup should we reach out to our hematology colleagues? Dr Patrick: I would say almost always. So, these disorders are inherently multi-system and benefit from early co-management. In acute sickle cell stroke, for example, hematology helps direct emergent exchange transfusion. For myeloproliferative disorders they guide cyto reduction and long term antithrombotic strategy. And for antibody mediated or plasma cell disorders, hematology determines disease specific therapies. So, neurology may help with identifying the presentation, but the definitive management is almost always shared with our hematology colleagues. Dr Nevel: And as you both have mentioned that a lot of times in these cases, their hematologic disorder may be already known before they present with their neurological symptoms. So, I imagine obviously in those cases that a hematologist hopefully is already heavily involved in their care. What do you think is the most difficult aspect of identifying and diagnosing patients with neurologic illness as having an underlying hematological disorder? Dr Patrick: The hardest part is maintaining a high index of suspicion, especially since hematologic causes account for a very small minority of arterial strokes. Most strokes are from traditional vascular risk factors like you mentioned, or cardio embolism, so it's easy to stop diagnostic evaluation after standard studies have been performed. An example of a challenging case is a patient that's young, they've had recurrent cryptogenic stroke, and they could have antiphospholipid antibody syndrome, but it can be easy to miss if their antibody titers are borderline or if they're already anticoagulated, which would complicate retesting. So, it's about balancing the urge to over-test with recognizing the few cases where identifying A hematologic cause truly changes that management. Dr Terrelonge: And then on the neuropathy side, probably the hardest part is deciding what's causal and what's coincidence. Monoclonal gammopathy of unknown significance, or MGUS, is really common in older adults, so not every M-spike on an SPEP explains a neuropathy. And even sometimes there's times when the neurologic picture will develop a little bit faster than the hematologic one. So, it's hard to put the two together. Dr Nevel: Yeah. What's the most rewarding aspect of taking care of patients with complications from their hematologic disorders? Dr Patrick: It's deeply rewarding when a targeted diagnosis leads to a tangible improvement in that patient's care. For example, identifying A cryptogenic stroke is being due to myeloproliferative neoplasm or an inherited thrombophilia allows us to move from empiric treatment to possible disease specific strategy. It's really gratifying to give patients that clarity, to give them a diagnosis and in some cases prevent future events. Dr Terrelonge: Agreed. And even on the neuropathy side, almost all of the neuropathies that are hematologically related are treatable. So, it's so satisfying whenever you have a patient with say an anti-MAG neuropathy or Waldenström can start the patient on therapy, and you can see someone who's been having a progressive decline to stability and in those cases sometimes even significant recovery. Dr Nevel: Yeah, absolutely. Very rewarding when you can identify the problem and make it better. That's what it's all about. So, what are the future areas of research in this area? What do we still need to learn? Dr Patrick: There's still a lot to learn. I think we need better data on the safety of acute reperfusion therapy and antithrombotic agents, particularly in patients that are at dual risk for bleeding and thrombosis. Other examples, secondary prevention strategies and anti-phospholipid antibody syndrome. What's the best target INR? Do you add aspirin to warfarin or not? All of that is often left up to expert opinion. What's the best management for adults with sickle cell stroke? There are many open questions there. A lot of the protocols that we have in place for sickle cell patients that are adults as derived from pediatric literature and there's vast potential in terms of disease modifying therapies, especially in the fields of sickle cell disease and amyloidosis. And we'll need to reassess how those treatments may change neurologic outcomes. Dr Terrelonge: I think on the neuropathy side that having some form of new biomarkers to help us clearly know of the neuropathy and that hematologic illness are associated would be very helpful. On the treatment side, a lot of this is really being driven by the hematology space, but new therapies that treat hematologic plasma cell disorders, including some of the new BTK inhibitor, may be incorporated relatively soon into the algorithm for how we treat many of our patients. I'm excited to see what's to come from this. Dr Nevel: Wonderful. Thank you so much for sharing your knowledge with us today. I know I've certainly learned a lot by reading your article and through our discussion today. Highly encourage our listeners to read your wonderful article, which is a very thorough review of hematologic disorders and neurological complications. Again, today I've been interviewing Dr Lauren Patrick and Dr Mark Terrelonge on their article Neurologic Complications of Hematologic Disorders, which appears in the February 2026 Continuum issue on Neurology of Systemic Disease. Please be sure to check out Continuum Audio episodes from this and other issues. And as always, thank you so much to our listeners for joining today, and thank you so much to Lauren and Mark. Dr Terrelonge: Yeah, thank you so much for having us. Dr Patrick: Thank you so much for having us and for highlighting this topic. We hope the issue encourages clinicians to think broadly about hematologic causes of neurologic disease and to continue collaborating closely with our hematology colleagues. It's a complex but very fascinating intersection for both of our fields. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/AudioCME. Thank you for listening to Continuum Audio.
Hey Voices from the Bench community! Jessica Love here, sending a shoutout from Utah! If you're passionate about creating natural, beautiful smiles—but want to simplify your workflow without sacrificing aesthetics—this is for you. I'm honored to be part of Ivoclar's development team introducing a powerful new stain and glaze system featuring Structure Paste, IPS e.max Ceram Art. Create stunning depth and lifelike color in as little as one firing. Let's continue to innovate, simplify, and create meaningful change—one smile at a time. Elvis actually made it down to the exhibition halls this year — and hyperDENT from FOLLOW-ME! Technology was everywhere. Booth after booth, people were talking milling strategies, templates, and workflows. It felt like a full-on CAM takeover. Their Milling Roadmap scavenger hunt had attendees bouncing between Axsys, Imagine, D.O.F., and Roland collecting stamps like responsible adults… Responsible adults chasing a bright orange folding electric hyperDENT scooter. That's what we love about the FOLLOW-ME! team — world-class CAM engineers talking microns and validation protocols one minute, then ripping around Lab Day the next. Serious about precision. Not too serious about themselves. Big shoutout for bringing the brains — and the electric horsepower. Come see and talk to Elvis and Barb at all these amazing shows in 2026* Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week we finally get Jay Collins to stop dodging Elvis long enough to sit down and share one of the wildest journeys in dental lab history. From a family split between union steamfitters and dental technicians in Philadelphia to surviving “The Great Brotherly Lab War,” Jay's story is packed with grit, loyalty, and a whole lot of Irish Catholic chaos. What started with an uncle drafted into dental technology during Vietnam eventually turned into a multi-generation lab legacy—and Jay swearing he'd never get into teeth… only to build a powerhouse anyway. After the 2008 crash wiped out his construction business, Jay bet everything on selling outsourced restorations door-to-door, sleeping in his car, showering at the gym, and cold-calling hundreds of offices a week. What followed was the development of his unapologetically bold, psychologically savvy sales approach—what he calls being “aggressively calm.” From pushing doctors to “no,” to matching their energy toe-to-toe, to walking into offices as “the lab” and walking out with cases in hand, Jay breaks down the mindset shift most lab owners desperately need: sales isn't optional, and it definitely isn't accidental. Now leading multiple lab locations under the brilliantly simple name thedentallab.net, Jay shares hard truths about growth, mergers, firing abusive clients, and why cutting your sales department in tough times is the worst move you can make. If you've ever struggled with prospecting, scaling, or standing your ground with doctors, this episode is packed with practical strategies, hilarious role-playing, and a reminder that confidence—backed by accountability—wins every time. At Canadian Dental Labs, Icortica has become a cornerstone of how we operate—giving us at-a-glance visibility into performance, helping us focus our efforts, spot opportunities early, and solve problems before they grow. It takes the guesswork out of decision-making and shows us what to do next. Plus, the Icortica team is incredibly responsive and feels like a true partner in our success. If you're serious about growing your business and understanding your customers better, Icortica can get you there. Learn more at icortica.com/voices — Icortica, helping dental labs grow. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the Women in Dentistry Lunch, celebrating career growth, wellbeing, and the real stories shaping our profession. And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off.Special Guest: Jay Collins.
Welcome to the 80th Episode of the What THE Golf Podcast, brought to you by Pen15 Golf! (3:45) Beers and Cheers - Straight Outta the Laboratory by Equilibrium Brewery (12:00) Eddie's elbow surgery (25:30) A wedding! (31:00) Kevin's chase of 300 yards carry (37:45) LIV and PGA Tour Update Thanks to Marillion for the opening and closing song!
0:00 SEGMENT 1: Kat Cressida (aka: Dee Dee) and Eddie Deezen (aka: Mandark) for a mini Dexter's Laboratory reunion!! We'll discuss their various voice roles, their upcoming convention appearances AND we'll also take YOUR calls and questions throughout the broadcast!19:04 SEGMENT 2: Breaking into voiceover with Kat and Eddie.https://www.instagram.com/katcressida/ https://www.instagram.com/thegreasenerd/ 46:11 SEGMENT 3: My conversation with one of my very favorite late-night hosts of all-time - Craig Ferguson! We talk about his voice-over work, his current comedy tour, and his new series coming out later this year!Keep up to date with 2 Rivers Comic Con, coming back to St. Charles in April 2026 https://2riverscomiccon.com/stay-in-touch/ Check out the ‘Justice League Revisited Podcast' with Susan Eisenberg and James Enstall at https://anchor.fm/justiceleague Thanks to our sponsors Historic St. Charles, Missouri (https://www.discoverstcharles.com/), Bug's Comics and Games (https://www.facebook.com/profile.php?id=100070575531223)Buy Me a Coffee - https://www.buymeacoffee.com/3Y0D2iaZl Patreon - https://www.patreon.com/GeekToMeRadio Website - http://geektomeradio.com/ Podcast - https://anchor.fm/jamesenstall Facebook - https://www.facebook.com/GeekToMeRadio/ Twitter - https://twitter.com/geektomeradio Instagram - https://www.instagram.com/geektomeradio/ Producer - Joseph Vosevich https://twitter.com/Joey_Vee
We're going back to the Moon. The planned March 2026 launch of Artemis II is the first crewed mission to the moon since 1972. Historic as it is, it isn't the only lunar event creating a stir at NASA. Two seismometers are to be delivered to Schrödinger's Crater in a mission called The Farside Seismic Suite, in which the instruments will measure moonquakes and record the possible impact of asteroid 2024 YR4 on lunar surface. Meanwhile, studies of the sun are heating up. The so-called PUNCH mission, a four-satellite constellation that will create an image of the sun's corona and solar winds, may help us better understand what drives solar storms and how we can protect Earth from their energetic blasts. Guests: Eugene Cernan – Apollo 17 astronaut Harrison "Jack" Schmitt – Geologist and Apollo 17 astronaut Andrew Rivkin – Planetary astronomer at the Applied Physics Laboratory at Johns Hopkins University Ceri Nunn – Lunar seismologist and planetary scientist, NASA's Jet Propulsion Laboratory Ryan French – solar physicist, at the Laboratory for Atmospheric & Space Physics, Boulder, Colorado, and author of “Space Hazards: Asteroids, Solar Flares and Cosmic Threats” Craig DeForest – Heliophysicist, Southwest Research Institute, principal investigator on NASA's PUNCH mission Featuring music by Dewey Dellay and Jun Miyake Big Picture Science is part of the Airwave Media podcast network. Please contact advertising@airwavemedia.com to inquire about advertising on Big Picture Science. You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support! Learn more about your ad choices. Visit megaphone.fm/adchoices
Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Walking the Lab Day Chicago floor? Make it worth it. Stop by the FOLLOW-ME! hyperDENT booth (E-27, East Hall) and take part in their Milling Roadmap—a quick, scavenger-hunt-style activity that leads you to key milling partners like Axsys, Imagine, DOF, and Roland. Collect stamps at booths you're likely visiting anyway and get entered to win some great giveaways—including this year's grand prize: a foldable Honda electric scooter. You're already walking the floor. Now it might carry you. Come see and talk to Elvis and Barb at all these amazing shows coming up in 2026* Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week we finally sit down with the one and only Matthew Douglas — technician, educator, denture-setting machine, former Affordable legend, past DLAT president, and all-around force of nature out of Texas. Matt's story starts with baseball. A promising career cut short by a hip injury (the “Bo Jackson thing,” as he calls it) led him to find a different path — one that started at TSTI in Waco and ended up shaping thousands of dentures, dozens of labs, and one of the fastest-growing state dental lab associations in the country. From living in an RV at the end of an airport runway while in school… to learning how to tear down porcelain ovens and rebuild lathes… to mastering ambidextrous denture setups with a soldering iron (yes, really), Matt built his foundation the old-school way. And he built it fast. We dive deep into his 12-year run with Affordable Dentures — managing high-production labs doing 60+ arches a day, training technicians across the country, helping open over 200 sites, and eventually becoming a regional leader. He shares what it takes to build systems that move that kind of volume — staggered lunches, zero idle time, and a whole lot of hustle. From there, Matt takes us through Barksdale Dental Lab, the early days of All-on-4, learning analog conversion workflows before digital streamlined everything, and why zirconia has changed the long-term game for full-arch restorations. When Matt returned to Texas and got involved with the Dental Laboratory Association of Texas (DLAT), the show had about a dozen booths. Today? Over 100. He breaks down how restructuring leadership, empowering the right people, removing outside management costs, and reinvesting in members transformed DLAT into one of the strongest state meetings in the country. If you want to grow your business, you need clear insight into what's happening inside your operation and across your customer journey. That's where Icortica comes in. At Canadian Dental Labs, Icortica has become a cornerstone of how we operate—giving us at-a-glance visibility into performance, helping us focus our efforts, spot opportunities early, and solve problems before they grow. It takes the guesswork out of decision-making and shows us what to do next. Plus, the Icortica team is incredibly responsive and feels like a true partner in our success. If you're serious about growing your business and understanding your customers better, Icortica can get you there. Learn more at icortica.com/voices — Icortica, helping dental labs grow. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the FIRST 5k run on the coast! And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off.Special Guest: Matthew Douglas CDT.
We're going back to the Moon. The planned March 2026 launch of Artemis II is the first crewed mission to the moon since 1972. Historic as it is, it isn't the only lunar event creating a stir at NASA. Two seismometers are to be delivered to Schrödinger's Crater in a mission called The Farside Seismic Suite, in which the instruments will measure moonquakes and record the possible impact of asteroid 2024 YR4 on lunar surface. Meanwhile, studies of the sun are heating up. The so-called PUNCH mission, a four-satellite constellation that will create an image of the sun's corona and solar winds, may help us better understand what drives solar storms and how we can protect Earth from their energetic blasts. Guests: Eugene Cernan – Apollo 17 astronaut Harrison "Jack" Schmitt – Geologist and Apollo 17 astronaut Andrew Rivkin – Planetary astronomer at the Applied Physics Laboratory at Johns Hopkins University Ceri Nunn – Lunar seismologist and planetary scientist, NASA's Jet Propulsion Laboratory Ryan French – solar physicist, at the Laboratory for Atmospheric & Space Physics, Boulder, Colorado, and author of “Space Hazards: Asteroids, Solar Flares and Cosmic Threats” Craig DeForest – Heliophysicist, Southwest Research Institute, principal investigator on NASA's PUNCH mission Featuring music by Dewey Dellay and Jun Miyake Big Picture Science is part of the Airwave Media podcast network. Please contact advertising@airwavemedia.com to inquire about advertising on Big Picture Science. You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support! Learn more about your ad choices. Visit megaphone.fm/adchoices
Professor Dante Lauretta discusses his book The Asteroid Hunter and his early career at the University of Arizona's Lunar and Planetary Laboratory, recalling how mentor Mike Drake and Lockheed Martin recruited him in 2004 for a daring asteroid sample return mission despite early rejections.
In this special episode, created by one of our student podcast fellows, NYU student Advait Sunil interviews Aditya Ramamurthy, Lab Manager at Movement Recovery Laboratory. Having received his MS in Biotechnology from the NYU Tandon School of Engineering, Aditya brought his “scientific mindset” to a new challenge: attending business school and supporting scientific ventures. Advait and Aditya speak about Aditya's curiosity growing up, how it led him to a career in research and innovation, and the connection between scientific thinking and business thinking.Aditya Ramamurthy is the Lab Manager at Movement Recovery Laboratory. After finishing his MS in Biotechnology at the NYU Tandon School of Engineering, he completed an MBA at Columbia Business School, focusing on management consulting and strategic decision-making. His diverse experience includes managing high-impact research projects and evaluating early-stage startups, with an ability to drive innovation and secure funding.For a full transcript of this episode, please email career.communications@nyu.edu.
This episode of The Laboratory with Plaz features hip-hop artist Compton AV and his producer Steelz — and trust us, you don't see AV doing interviews like this often.We dive into the story behind their breakout hit “Ya Ya”
Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Walking the Lab Day Chicago floor? Make it worth it. Stop by the FOLLOW-ME! hyperDENT booth (E-27, East Hall) and take part in their Milling Roadmap—a quick, scavenger-hunt-style activity that leads you to key milling partners like Axsys, Imagine, DOF, and Roland. Collect stamps at booths you're likely visiting anyway and get entered to win some great giveaways—including this year's grand prize: a foldable Honda electric scooter. You're already walking the floor. Now it might carry you. Come see and talk to Elvis and Barb at all these amazing shows in 2026* Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week we sit down with Michael Joseph, a London-based lab owner whose journey through dental technology is anything but traditional. From delivering impressions on a scooter through the streets of London to completely rebuilding his lab as a fully digital operation, Michael shares a candid, honest look at what it really takes to survive—and thrive—in today's dental lab landscape. Michael walks listeners through his early days pouring hundreds of stone models by hand, navigating education with dyslexia, and eventually earning his degree in dental technology. After years at the bench, he pivoted into dental sales, working with companies like Orascoptic, Sirona, and Skillbond/Argen—experience that gave him deep insight into materials, equipment, and the business side of dentistry. That sales background ultimately fueled his return to lab ownership and helped him build a strong network of clinicians from day one. The conversation takes a powerful turn as Michael opens up about the challenges of Brexit, COVID, staffing losses, and personal upheaval that nearly ended his lab altogether. Instead of quitting, he made a bold decision: gut the lab completely and rebuild it from the ground up as a fully digital operation. Investing heavily in milling, printing, Exocad, and workflow automation, Michael shares how committing to systems, protocols, and vertical integration transformed not just his lab—but his mindset. Elvis and Barb dig into Michael's digital workflows, including photogrammetry, full-arch immediate load cases, remote design teams, LMS integration with GreatLab, and why reliability and consistency are the real competitive advantages. Michael also explains how peer referrals—not ads—became his strongest growth engine, and how simplifying communication with dentists through WhatsApp, QR codes, automation, and self-booking systems has completely changed the way his lab operates.### If you want to grow your business, you need clear insight into what's happening inside your operation and across your customer journey. That's where Icortica comes in. At Canadian Dental Labs, Icortica has become a cornerstone of how we operate—giving us at-a-glance visibility into performance, helping us focus our efforts, spot opportunities early, and solve problems before they grow. It takes the guesswork out of decision-making and shows us what to do next. Plus, the Icortica team is incredibly responsive and feels like a true partner in our success. If you're serious about growing your business and understanding your customers better, Icortica can get you there. Learn more at icortica.com/voices — Icortica, helping dental labs grow. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the Women in Dentistry Lunch, celebrating career growth, wellbeing, and the real stories shaping our profession. And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off. Starting the year strong in the dental lab isn't about goals—it's about results. Predictable productivity is what drives real profitability, and unpredictability is costly when remakes rise and production slows. That's why labs rely on Roland DGA's DGSHAPE milling solutions. With consistent accuracy, minimal downtime, and automation you can count on, systems like the DWX-53DC deliver reliable output day after day—making ROI measurable and growth predictable. See consistency in action at LMT Lab Day Chicago, Booth I-20. Choose DGSHAPE. Crafted with Japanese precision. Trusted by dental professionals worldwide. Learn more at rolanddental.comSpecial Guest: Michael Joseph.
In this episode of ADK Talks, we step inside one of the most important scientific sites you've probably never heard of: the tuberculosis laboratory that helped put Saranac Lake on the global medical map.We're joined by Amy Catania, Executive Director of Historic Saranac Lake, who helps us trace how a small Adirondack village became a worldwide center for healing, research, and compassion at the turn of the 20th century.At a time when tuberculosis was killing one in seven people in industrialized countries, patients, doctors, and researchers from around the world came north chasing fresh air, rest, and hope. What they found reshaped medicine, architecture, and the identity of Saranac Lake itself.What you'll hear in this episodeHow tuberculosis, once called “consumption,” spread rapidly during industrialization and why cities like New York were especially deadlyThe remarkable story of Edward Livingston Trudeau, a young New York City doctor who came to the Adirondacks expecting to die and instead helped change modern medicineWhy Saranac Lake became home to what may be the first U.S. laboratory dedicated entirely to tuberculosis researchThe truth behind the “fresh air cure” and how rest, ventilation, and nursing care gave patients their best chance at recoveryCure cottages, cure porches, and how TB literally shaped the architecture of the villageWhy many cure cottages were run by women, and how this became an unexpected economic engine Inside Trudeau's laboratory: fireproof design, high ceilings, massive windows, and science before electricityThe famous Rabbit Island experiment and how it helped validate the sanatorium model worldwideHow Saranac Lake's TB years sparked everything from a booming downtown to the origins of the Winter CarnivalThe global reach of the cure, including thousands of patients from Latin America, Europe, and beyondWhat visitors can expect today at the laboratory museum and the exciting expansion into the restored Trudeau home opening in August 2026Resources:Historic Saranac Lake Website Historic Saranac Lake WikiADKtaste.com article The Pioneering Fight Against Tuberculosis in the AdirondacksEmbracing Winter Magic: The Saranac Lake Winter CarnivalSign Up For Our Newsletter and Visit the ADK Taste's WebsiteProduced by NOVA
How does an evaporative cooling vest keep your skin up to 5°C cooler for hours—without making you wet? José Näf shares how smart materials can transform temperature regulation. "Lean more about Nahtlos Duratrode electrodes at https://www.nahtlos.com/" In this episode, Dr. Olli Tikkanen continues the conversation with José Näf, co-founder of Duracool, focusing on the design, functionality, and physiological impact of evaporative cooling vests. These vests use semi-permeable membranes to gradually release water vapor, providing long-lasting cooling without soaking the user. José explains the technical design of their shoulder pads and vests, their application in both occupational settings and for individuals with medical conditions such as artificial menopause, and the importance of wearing them over—not under—clothing. Laboratory tests show their cooling performance lasts significantly longer than sponge-based vests, making them ideal for situations with moderate movement, like construction or low-intensity work in hot environments. This episode is a must-listen for professionals and researchers interested in thermal comfort and performance under heat stress. __________ This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behaviour and Physical Activity Research with Less Hassle --- Collect, store and manage SB and PA data easily and remotely - Discover ground-breaking Fibion SENS --- SB and PA measurements, analysis, and feedback made easy. Learn more about Fibion Research --- Learn more about Fibion Sleep and Fibion Circadian Rhythm Solutions. --- Fibion Kids - Activity tracking designed for children. --- Collect self-report physical activity data easily and cost-effectively with Mimove. --- Explore our Wearables, Experience sampling method (ESM), Sleep, Heart rate variability (HRV), Sedentary Behavior and Physical Activity article collections for insights on related articles. --- Refer to our article "Physical Activity and Sedentary Behavior Measurements" for an exploration of active and sedentary lifestyle assessment methods. --- Learn about actigraphy in our guide: Exploring Actigraphy in Scientific Research: A Comprehensive Guide. --- Gain foundational ESM insights with "Introduction to Experience Sampling Method (ESM)" for a comprehensive overview. --- Explore accelerometer use in health research with our article "Measuring Physical Activity and Sedentary Behavior with Accelerometers ". --- For an introduction to the fundamental aspects of HRV, consider revisiting our Ultimate Guide to Heart Rate Variability. --- Follow the podcast on Twitter https://twitter.com/PA_Researcher Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen Follow Fibion on Twitter https://twitter.com/fibion https://www.youtube.com/@PA_Researcher
In this episode, we're talking with Dr. Alaina Holt and Dr. Michelle Peace from the Laboratory for Forensic Toxicology Research about the importance of relationships within research, what they are seeing in the e-cigarette and cannabis product markets right now, the importance of sharing their findings with the community, and the role we all have to play in keeping our communities safe, healthy, and informed. Referenced Resources: VCU Department of Forensic Science: https://forensicscience.vcu.edu/ VCU Laboratory for Forensic Toxicology Research: https://blogs.vcu.edu/mrpeace/ LFTR Research Materials: https://drive.google.com/drive/folders/1rndBDBH8N5Ie18HM0JqT_wJ4NhKNdaR7?usp=sharing Virginia Foundation for Healthy Youth: https://vfhy.org/ Dr. Peace is a forensic toxicologist and a Full Professor in the Department of Forensic Science at VCU. She is one of the founding faculty for the Department and served as Associate Chair and Chair for nearly a decade. Dr. Peace has also served as a manager in a private forensic drug testing laboratory and has worked as a scientist for Procter & Gamble, where she holds 3 patents. Dr. Peace has been funded by the National Institute of Justice to study the efficacy of electronic cigarettes, particularly as they pertain to substance use and abuse. Dr. Peace serves on the Board for Virginia's Cannabis Control Authority, is a Past President of the Society of Forensic Toxicologists, is a member of The International Association of Forensic Toxicologists and is a Fellow in the American Academy of Forensic Sciences. She is a member of the National Safety Council's Alcohol, Drugs, and Impairment Division. Dr. Holt is a forensic toxicologist and an Associate Research Faculty member in the Department of Forensic Science at Virginia Commonwealth University. She works within the Laboratory for Forensic Toxicology research where she assists students, maintains instrumentation, and completes casework. Her current research includes characterizing vaping products confiscated from Virginia school students; characterizing cannabis and cannabinoid-products for quality and labeling accuracy; assessing impacts of vaping on alcohol impairment evaluations; and evaluating novel treatments for opioid overdoses. Dr. Holt is an active member of the Society of Forensic Toxicologists, The International Association of Forensic Toxicologists, the American Academy of Forensic Sciences, the International Association of Chemical Testing, and the International Association of Chiefs of Police. Dr. Holt is also a member of the National Safety Council's Alcohol, Drugs, and Impairment Division. The views and opinions expressed on Awareness 2 Action are those of the guests and host and do not necessarily reflect the official policy or position of the Prevention Department or Northwestern Community Services.
In this episode, we explore the often-overlooked art of communicating effectively with your dental laboratory.Dentists and technicians exchange information daily across multiple channels and on a vast range of clinical and technical matters. Yet, as Dentolegal consultant, Dr Simon Parsons notes, many opportunities to strengthen this communication and ultimately improve clinical outcomes are frequently missed.To understand why this happens and what clinicians can do to bridge the gap, Dr Annalene Weston speaks with Simon, who brings a unique dual perspective shaped by his time working within a large dental laboratory and his own clinical experience. Join us for a conversation that may just transform the way you work with your lab.
Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Walking the Lab Day Chicago floor? Make it worth it. Stop by the FOLLOW-ME! hyperDENT booth (E-27, East Hall) and take part in their Milling Roadmap—a quick, scavenger-hunt-style activity that leads you to key milling partners like Axsys, Imagine, DOF, and Roland. Collect stamps at booths you're likely visiting anyway and get entered to win some great giveaways—including this year's grand prize: a foldable Honda electric scooter. You're already walking the floor. Now it might carry you. Come see and talk to Elvis and Barb at all these amazing shows coming up in 2026* Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week Elvis and Barb sit down with Helen Tanaka — a removable, implant, and digital workflow specialist whose career started in one of the most relatable ways possible: as a dental lab driver. What began as a job delivering cases quickly turned into a full-blown passion once she stepped inside the lab and saw what technicians were creating. From trimming dies and waxing copings to managing labs, supporting implant surgeries, teaching doctors chairside, and leading removable and implant teams, Helen shares a journey built on curiosity, persistence, and a deep drive to understand the why behind everything in dental technology. Helen talks about working her way through crown and bridge fundamentals before discovering her true passion in removables, dentures, implants, and occlusion. After getting real-world lab experience, she attended dental technology school, studied all six specialties, and continued expanding her knowledge through advanced occlusion training and continuing education. She explains why understanding morphology, materials, and occlusal principles is critical — especially today — and why technicians must know more than just the steps of fabrication. For Helen, dentures and implant prosthetics offer the ultimate puzzle, combining anatomy, function, and problem-solving in ways that keep her constantly engaged. The conversation dives deep into digital dentistry, guided surgery, and removable workflows, with Helen sharing her early experiences launching digital denture and sleep appliance programs long before the workflows were polished. She discusses digital record capture, stackable surgical guides, implant planning, photogrammetry, and where digital still needs improvement — especially for removable prosthetics. While she embraces technology, she stresses that software is only as good as the technician behind it, and that skipping fundamentals creates bigger problems later. Digital is powerful, but it doesn't replace understanding. Education is a major theme throughout the episode. Helen regularly teaches doctors and technicians, speaks at courses, supports live implant conversions, and works with dental students. She emphasizes that many clinicians today lack confidence in dentures and removable workflows, often because fundamentals are under-taught, and she sees technicians as essential partners in closing that gap. She and the hosts discuss how removable cases are frequently rushed, underpaid, and misunderstood — even though they replace a critical body function — and why slowing down, capturing correct records, and returning to basics solves many of the “mystery” failures labs see every day. Helen also shares stories from her time with large organizations and clinical teams, including MicroDental, ClearChoice, Arklign, and implant education centers, where she has worked in technical service, management, training, and quality oversight roles. She talks about networking, mentoring, never burning bridges, and investing in people coming up in the industry. Her approach to both dentistry and life centers around curiosity and accountability — always asking why, always backing decisions with data, and always trying to do the right thing even when no one is looking. Throughout the episode, the energy stays fun and honest, with stories about speeding delivery runs, early digital growing pains, chairside save-the-case moments, and the reality of fixing cases that skipped key steps. Helen brings passion, technical depth, and a strong belief that knowledge should be shared, not guarded. It's a conversation about growth, fundamentals, digital evolution, and why great technicians still matter more than ever. If you want to grow your business, you need clear insight into what's happening inside your operation and across your customer journey. That's where Icortica comes in. At Canadian Dental Labs, Icortica has become a cornerstone of how we operate—giving us at-a-glance visibility into performance, helping us focus our efforts, spot opportunities early, and solve problems before they grow. It takes the guesswork out of decision-making and shows us what to do next. Plus, the Icortica team is incredibly responsive and feels like a true partner in our success. If you're serious about growing your business and understanding your customers better, Icortica can get you there. Learn more at icortica.com/voices — Icortica, helping dental labs grow. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the FIRST 5k run on the coast! And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off.Special Guest: Helen Tanaka.
Toward the end of his life, the great inventor Thomas Edison became obsessed with one final project: finding a source of rubber that could grow in the United States. It would transform his Florida home into a bonafide botanical laboratory.This episode was produced in partnership with Fort Myers – Islands, Beaches and Neighborhoods. Find more information about the Edison and Ford estates here. If you'd like to learn more about Edison's life in Florida check out this biography by Michele Wehrwein Albion. Find out more information about Henry Ford's search for rubber sources in a previous episode of the Atlas Obscura podcast, “Fordlandia.”We always want to hear from you! If you have a question or story for us, give us a call at 315-992-7902 and leave a message, or send an email to hello@atlasobscura.com. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Walking the Lab Day Chicago floor? Make it worth it. Stop by the FOLLOW-ME! hyperDENT booth (E-27, East Hall) and take part in their Milling Roadmap—a quick, scavenger-hunt-style activity that leads you to key milling partners like Axsys, Imagine, DOF, and Roland. Collect stamps at booths you're likely visiting anyway and get entered to win some great giveaways—including this year's grand prize: a foldable Honda electric scooter. You're already walking the floor. Now it might carry you. We welcome back longtime friend of the podcast John Wilson of Sunrise Dental Lab, returning for the first time since 2021—and this time as a fellow podcaster himself. What starts as a warm reunion quickly turns into a deep, honest conversation about passion, purpose, integrity, and what it really takes to survive (and stay sane) in today's dental lab world. John reflects on the evolution of his lab, sharing why he made the intentional decision not to chase endless growth, but instead to protect his team, his values, and his love for the craft. He talks candidly about “yesterday thinking,” adapting to digital dentistry without abandoning fundamentals, and why aligning with the right clients—not just more clients—changed everything. The discussion dives into what true lab–doctor partnerships look like, why trust is earned (not given), and how saying “no” can sometimes be the most powerful business decision you make. John also explains why single units matter just as much as full-arch cases, how education keeps technicians relevant, and why racing to the bottom on price is a losing game. Later, the conversation turns personal as John shares the inspiration behind his new solo podcast, Margins & Meaning—a storytelling-driven project created to document his journey, connect with technicians who feel alone, and leave something meaningful behind for the next generation. He opens up about legacy, creativity, fear, change, and why being heard matters just as much as having something to say. Join us at exocad Insights 2026, happening April 30–May 1, 2026, on the stunning island of Mallorca, Spain. This two-day event features powerhouse keynotes, hands-on workshops, live software demos, and top-tier industry showcases—all in one unforgettable setting. Barb and Elvis will be on site bringing you exclusive interviews, plus don't miss the Women in Dentistry Lunch, celebrating career growth, wellbeing, and the real stories shaping our profession. And of course, cap it all off with the legendary exoGlam Night under the stars. Tickets are limited. Visit exocad.com/insights-2026 and use code VFTBPalma15 for 15% off.Special Guest: John Wilson.
In this episode, Donnie Rosario, System Vice President of Laboratory Services at CommonSpirit Health, shares insights on leading large scale lab operations, addressing workforce and financial pressures, and using data, automation, and trust driven leadership to translate strategy into consistent operational results across a national health system.
A compilation of three shows on the Idaho National Laboratory:A Peace of the Nuclear Puzzle: From Nagasaki to the Idaho National Laboratory (8/12/24)Incurring on Disclosure: Idaho's Atomic Marvels (6/28/22)Untold History of Idaho's National Lab: From Nuclear Experiments to UFOs (6/7/21)*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.WEBSITEFREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVE-X / TWITTERFACEBOOKINSTAGRAMYOUTUBERUMBLE-BUY ME A COFFEECashApp: $rdgable PAYPAL: rdgable1991@gmail.comRyan's Books: https://thesecretteachings.info- EMAIL: rdgable@yahoo.com / rdgable1991@gmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.
In this episode of The Poultry Nutrition Blackbelt Podcast, Dr. Sami Dridi from the University of Arkansas explains the molecular and physiological impact of beta mannan on poultry health and performance. He breaks down how beta mannan triggers inflammation, affects gut integrity, and reduces feed efficiency, and he shares research on how beta mannanase can counter these challenges. Listen now on all major platforms!"Beta mannan creates physiological, immunological, and metabolic challenges that influence overall nutrient use and bird performance."Meet the guest: Dr. Sami Dridi is a Professor at the University of Arkansas, leading the Laboratory of Avian Endocrinology and Molecular Genetics within the Center of Excellence for Poultry Science. His research explores heat stress responses, intestinal integrity, and metabolic disorders such as muscle myopathies in poultry. His recent work examines beta mannan and beta mannanase effects on performance and gut health. Listen to this Poultry Nutrition Blackbelt Podcast episode with Dr. Sami Dridi on all major platforms.Liked this one? Don't stop now — Here's what we think you'll love!What you'll learn:(00:00) Highlight(01:39) Introduction(03:45) Beta mannan effects(05:19) Gut integrity impact(06:57) Enzyme function(07:46) Performance results(10:50) Future applications(13:07) Closing thoughtsThe Poultry Nutrition Blackbelt Podcast is trusted and supported by innovative companies like: BASF* Kemin* Fortiva- Anitox- Poultry Science Association- DietForge
Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday Almost three years after his last appearance, Rob Nazzal returns to Voices From the Bench, this time joined by Mike Alessio of Bonadent Dental Laboratory (https://bonadent.com/). The conversation dives deep into lab leadership, culture, transparency, and how data—when used the right way—can empower teams instead of policing them. Mike shares his 32-year journey with Bonadent, from starting as a pickup-and-delivery driver to leading the Danaren division, and explains how a family-owned lab has grown into a multi-location organization without losing its people-first culture. Rob and Mike unpack the realities of tracking productivity on the lab floor, the challenges of sharing metrics openly, and why transparency builds trust, alignment, and accountability when done with intention. The discussion shifts to quality vs. productivity, the difficulty of truly measuring “quality,” and why labs must lead with craftsmanship before numbers. They also explore how digital workflows, QC processes, and proactive communication with doctors impact remakes, efficiency, and relationships. On the sales side, Rob breaks down how icortica (https://www.icortica.com/voices) helps labs grow by focusing on existing customers, improving retention, and giving sales teams real-time insights into what conversations they should be having—right before they walk into an office. Mike and Elvis share firsthand experiences using icortica (https://www.icortica.com/voices), highlighting how real-time data, centralized notes, and smart alerts change the way sales reps prepare, prioritize, and perform. The episode wraps with a look at Bonadent's unique culture (including their famous converted Walmart lab), long employee tenure, and why investing in people, transparency, and the right technology is the real key to sustainable growth in today's dental lab landscape. If you want to grow your business, you need clear insight into what's happening inside your operation and across your customer journey. That's where Icortica comes in. At Canadian Dental Labs, Icortica has become a cornerstone of how we operate—giving us at-a-glance visibility into performance, helping us focus our efforts, spot opportunities early, and solve problems before they grow. It takes the guesswork out of decision-making and shows us what to do next. Plus, the Icortica team is incredibly responsive and feels like a true partner in our success. If you're serious about growing your business and understanding your customers better, Icortica can get you there. Learn more at icortica.com/voices — Icortica, helping dental labs grow. Special Guests: Mike Alessio and Rob Nazzal.
Common law can feel like a chaotic patchwork of 50 different jurisdictions. But for the last century, the American Law Institute (ALI) has worked to distill that chaos into clear, persuasive principles. We sit down with Mark Hall, the lead reporter for the Restatement of the Law Third, Torts: Medical Malpractice, to discuss how these influential texts are written and why they often carry more weight than a standard law review article.In this episode, we cover:The "Goldilocks" Standard: How the ALI synthesizes the "best" version of the law from conflicting state approaches.Medical Malpractice Deep Dive: Defining the "Standard of Care" and navigating the controversial Loss of Chance doctrine.A "Secondary" Source with Primary Power: Why judges often rely on Restatements to settle issues of first impression.The Laboratory of the States: Why a little legal variation across the country is actually a good thing for the profession.(00:00) - Introduction: The Chaos of Common Law and the Role of the ALI (03:24) - What is a Restatement? Harmonizing 50 States into One Principle (04:36) - The Legacy of Torts: How the ALI Created Products Liability Law (07:17) - Defining the Standard of Care: "Competent" vs. "Average" (09:55) - The "Loss of Chance" Doctrine: Can You Sue for a Reduced Probability of Survival? (12:14) - Study Tips: Using Restatements to Outline for Finals and Understand Nuance (16:24) - Litigation Strategy: Making Arguments When the Law is Unsettled (20:00) - The "Laboratory of the States": Why Legal Variation is Beneficial (24:32) - Curriculum Design: Will Professors Teach from the Restatement? (27:38) - Host Debrief: How to Use Restatements as a Research Shortcut for Briefs (34:40) - Evidence vs. Torts: Why Codified Rules Feel Easier to Learn (42:02) - Networking Hacks: Using the ALI Member List to Find Mentors Click here to view the episode transcript.
We are often told exercise is good for boosting your mood, but a new Cochrane review has looked at what the evidence says about how much difference exercise can really make when treating depression.Many patients with chronic conditions fail to take medications as prescribed. We discuss a novel pill casing that can send a signal once it has been broken down in the stomach. Prof Giovanni Traverso, gastroenterologist and director of the Laboratory for Translational Engineering at MIT, explains how it works.A year on from the USAID freeze, global health journalist Andrew Green unpicks America's radically different influence on world health today. In Malawi's townships, many families can no longer afford charcoal or gas. Instead, they turn to burning plastic waste as cooking fuel. This keeps food on the table but fills kitchens and markets with toxic smoke, contributing to respiratory illness, pregnancy complications, and environmental damage. We hear from our reporter, Carrim Mpaweni.And we look at auto-brewery syndrome as researchers search for why some people's gut microbes produce high alcohol levels.Presenter: Claudia Hammond Producer: Hannah Robins Assistant producers: Jonathan Blackwell and Anna Charalambou
Butyrate is a short-chain fatty acid (SCFA) produced when gut bacteria ferment dietary fiber. It provides energy for colon cells and offers health benefits beyond basic nutrition Research suggests butyrate helps manage inflammatory bowel disease (IBD) by reducing inflammation, improving symptoms and strengthening gut barrier integrity Laboratory studies show butyrate helps inhibit cancer cell growth and trigger cell death in colorectal cancer cells, with clinical trials exploring its use alongside traditional treatments Butyrate has been shown to improve insulin sensitivity and glucose metabolism in metabolic disorders, while also influencing appetite-regulating hormones Studies show butyrate protects against neurodegenerative diseases by reducing brain inflammation and enhancing neuronal repair and survival
Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. In this episode, Elvis and Barb sit down with Dr. Miles Cone, a prosthodontist whose path into dentistry is anything but traditional. From a childhood obsession with dinosaurs and living out of his Jeep, to serving in the Army and becoming a CDT, Dr. Cone shares how persistence, humility, and an appreciation for the lab side of dentistry shaped his career. Along the way, he opens up about failing the CDT exam, learning the true value of dental technicians, and why collaboration—not ego—is the key to better patient outcomes The conversation also dives deep into photography, storytelling, and seeing dentistry as both science and art. Dr. Cone explains how discovering dental photography transformed not only how he documents cases, but how he connects with patients and technicians alike. He and Barb and Elvis discuss raising your skills by putting your work out there, ignoring the trolls, and using critique to grow. The episode wraps with a preview of Dr. Cone's upcoming Ivoclar presentation at Lab Day Chicago (https://lmtmag.com/seminars/hiding-in-plain-sight-creating-fake-teeth-for-real-people-in-the-age-of-cosmetic-cliche), where he and technician Janelle will show how dentures and removables can be “hidden in plain sight” when done with intention, artistry, and respect for the entire dental team. A new year is the perfect time to reset, refocus, and set your dental business up for success. January isn't just about new goals—it's about working smarter with efficient, reliable systems that keep production running smoothly and predictably. Roland DGSHAPE milling solutions (https://www.rolanddga.com/products/dental/dwx-series) deliver the consistency and automation labs depend on to control costs, reduce remakes, and maximize every hour. With trusted Japanese engineering and mills like the DWX-53DC (https://www.rolanddga.com/products/dental/dwx-53dc-5-axis-dry-dental-milling-with-automatic-disc-changer) working even when you're not, you spend less time fixing problems and more time growing your business. Start the year strong with solutions built for productivity and profitability. That's the Roland DGSHAPE difference. Learn more at rolanddental.com Special Guest: Dr. Miles Cone.
David Jernigan 0:15Hello! Dr. Deb 0:16Hi there, sorry for all the confusion. David Jernigan 0:19Oh, no worries, you gotta love it, right? Dr. Deb 0:21Oh, I can’t hear you. David Jernigan 0:23No way, let’s see, my mic must be turned off? Dr. Deb 0:27Hang on, I think it’s me. Let’s see…Okay, let’s try now. David Jernigan 0:40Okay, can you hear me? Dr. Deb 0:42Yep, I can hear you now. David Jernigan 0:43Excellent, excellent. And, how are you today? Dr. Deb 0:48I am good, thank you. How about yourself? David Jernigan 0:50I’m good. Well, it’s good to finally meet you and get this thing rolling. Dr. Deb 0:56Yes, yes, I’m so sorry about that. David Jernigan 0:58That’s alright, that’s alright.So… Dr. Deb 1:01Yeah, go ahead. David Jernigan 1:03So, tell me about yourself before we get going. Dr. Deb 1:06Yeah, so I am a nurse practitioner. I’m also a naturopath. I have a practice here in Wisconsin. I’ve been treating Lyme for about 20 years, so I’m really excited to have this conversation and learn what you’re doing, because it’s so exciting and new. David Jernigan 1:21Well, thank you. Dr. Deb 1:22Yeah, so we treat a lot of chronic illness patients, do some anti-aging regenerative things as well, so… David Jernigan 1:30Yeah, I went to your website and saw you guys are killing it, looks like. Dr. Deb 1:35Yeah. David Jernigan 1:35Got a lot of good staff, it looks like. Dr. Deb 1:37Yeah, we’ve got great staff, great patients, busy practice. We have 5 practitioners, so we have about 15,000 patients in our practice right now. David Jernigan 1:46Well, excellent. Yeah. Excellent. Yeah, yeah.So, I’m excited for this discussion. Dr. Deb 1:53Good, me too. So I pre-recorded our intro, so we can just kind of dive right in, and I’ll just ask you to kind of introduce yourself a little bit, tell us a little bit about yourself, and, and then we can just dive right into it. David Jernigan 2:08All right. I’m Dr. David Jernigan, and I own the Biologic Center for Optimum Health in… Franklin, Tennessee, and I’ve been in practice for over 30 years. I shook Willie Bergdurfer’s hand, if anybody knows who that is. It’s kind of infamous now with some of the revelations that have happened about Lyme being a bioweapon and weaponized. But, you know, I’ve been doing this, probably longer than almost anybody that’s still in the business in the natural realm. It chose me. I did not choose Lyme. Matter of fact, there were many times in my career that I was like. You know, cancer’s easier because of the fact that everybody agrees, you know, what we’re dealing with. And in the 90s, it was a whole different reality, where nobody actually understood that you could have Lyme disease and not be coming from New England.You know, so I had actually the first documented case of a Lyme disease, CDC positive.Patient that had never left the state of Kansas before. So they couldn’t say that it wasn’t in Kansas, and so she had actually been, pregnant with… twin boys, and they were born CDC-positive as well, and so it is transmitted across the placenta we know.So, I, you know, the history of how I did all this was, in the 90s, probably 1996, probably, somewhere in there, 97. With this woman, you know, I… if you go into Robin’s pathology books from back then. Which we all used, medical doctors and everybody else studying. you know, there was basically a paragraph about Lyme disease, and on the national board tests, as you recall, it was probably like, what causes, or what is, bullseye rash associated with? And you’d had to guess Lyme disease, of course. Dr. Deb 4:07Female. David Jernigan 4:08But that was, you know, considered to be more a New England illness, and you would never see it anywhere else. But here was this woman. I knew… nothing about Lyme beyond what we had gotten taught in college, which was, like I say, next to nothing. And she would not let me stop feeding me information. I mean, you gotta remember, the internet wasn’t even hardly in existence in those years. I mean, it was brand new. It was supposed to be this information highway, and So I started purchasing, like a lot of doctors do even now, they start purchasing every kind of new supplement that’s supposed to work for bacteria. There was no product in those days that actually was Lyme-specific. I mean, nobody was really dealing with it naturally. It was always a pharmaceutical situation. Dr. Deb 5:04And a very short course at that. David Jernigan 5:06Yeah, 2 weeks of doxy and you’re cured, whether your symptoms are gone or not, which… she’d had the 2 weeks of doxy, and her symptoms and her son’s symptoms were not gone. And so, I absolutely just purchased everything I could find. Nothing would work. I mean, I could name names of products, and you would recognize them, because they’re still out there today. Dr. Deb 5:28Which is. David Jernigan 5:30Kind of a… A sad thing that natural medicine is still riding on these things that have the most marketing. Dr. Deb 5:37As opposed to sometimes the things that actually have the documented research. David Jernigan 5:42Behind it, and I am a doctor of chiropractic medicine, and I specialized all these years in chronic, incurable illnesses of all types. That may sound odd to a lot of people, but doctors of chiropractic medicine are trained just like a GP typically would be. The medical schools, as I understand it, got together, decades ago and said, wow, if all we did was… Crank out general practitioners for the next 10 years, we wouldn’t have still enough general practitioners to supply the demand. Dr. Deb 6:17Right. Everybody in medicine, in medical schools, wanted to be a specialist, because that’s where the money was, and it was… David Jernigan 6:24Easier, kind of, also, to… you know, just focus on one part of the body, and specialize in that. Dr. Deb 6:31Expert in that one area. David Jernigan 6:32So we all now have the same training. We all go through pre-med. We got a bachelor’s degree, I got my bachelor’s degree in nutrition, and through, Park University in Parkville, Missouri. And so, you know, when I ran out of options to purchase, I just used a technology that I developed, which was an advancement upon other technologies, but I called it bioresonance scanning. And I coined the term back in the 90s. It was a way to kind ofKind of like a sensitive test, you know, like you might. Dr. Deb 7:09I wouldn’t. David Jernigan 7:09Of applied kinesiology, then clinical kinesiology, then chiro plus kinesiology, then, you know, you can just keep going with all the advancements that were made. Well, this was an advancement upon those things, so… I developed… I was the first in… in… my known world of doctors to develop a way to detect adjunctively, obviously we can’t say it’s a primary diagnosis. Adjunctively detect the presence of a given specimen. So we could say, thus saith my test. It’s highly likely you have Borrelia burgdurferi. And, but I had to have the specimen on hand to be able to match what I call frequency matching to the specimen. Brand new concept in those days. And so I was able to detect whether or not my treatments were successful or not. This is something even now that’s really difficult for doctors, because antibody tests, even the most advanced ones, it’s still an antibody test. It’s still an immune response to an infection.And accurately, you know, some doctors will slam those tests, saying, well. That doesn’t mean you actually have the infection, that just means your body has seen it before, which is a correct statement, kind of. So being able to detect the presence, and even where in the body these infections are was a way huge advancement in the 90s, for sure it’s kind of funny, I think about a conference I went to, and cuz… I’m kind of jumping ahead. Because I ended up developing my own formula, just for this woman and her children, and it worked. And I was like, wow! Their symptoms were gone, all the blood tests came back negative. In those days, we were using the iGenX. Western blot, eventually. And the, what was called a Lyme urine antigen test. I don’t know if you remember that, because it… Only decades later did I meet, the owner of iGenX, Nick Harris. Dr. Deb 9:17Person. And I was like, whatever happened to the Luwat test? Because I took it off the market after a while. He said, honestly, we lost the antigen and couldn’t find it again. Oh, no. David Jernigan 9:27And so… but that was a brilliant test. It was the actual gold standard in those days. Again, the world… it can’t be understated how different the world was in the 90s. Dr. Deb 9:40Yeah. David Jernigan 9:41Towards natural medicine, even. Dr. Deb 9:44Oh, yeah. We think… we think it’s bad now, but, like, when I started, too, I started in the early 2000s, like, we were all hiding under the radar, like, you didn’t market, we would have never been on social media, we didn’t run ads, we didn’t do any. David Jernigan 10:00Right. Dr. Deb 10:01Because the medical boards were coming for us. David Jernigan 10:04Came after me. Dr. Deb 10:05Because I had the word Lime on my page, my website. David Jernigan 10:10You know, not saying that I treat Lyme. Dr. Deb 10:13Hmm? David Jernigan 10:13Yes Dr. Deb 10:15Just talking about mind. David Jernigan 10:16And it’s funny, because, once I had this formula, it was something… and I trained in Germany, in anthroposophical medicine, and they’ve been trained in herbal… making herbal extracts, making homeopathic remedies in the anthroposophical methodology, and I trained with the Hahnemann versions of homeopathy, which is just slightly different. Yeah. And, so I was well-versed with making some of my own formulas by that time. And so, it was really something that I wrote on the bottle, you know, and I had to call it something, so I called it Borreligin, which is still in existence, and it’s still a phenomenal herbal remedy right now. And to my knowledge, it’s the only frequency-matched herbal formula. Maybe still out there. Because unless you knew how to do my testing, the bioresonent scanning, there was no way to actually do frequency matching. Matter of fact, as a really famous herbalist attacked me online, saying, oh, none of these herbs will kill anything. And I’m like, that wasn’t what I was saying. I was saying, back in those days, I was saying, well, if… what would the body need to address these infections?You know, not, like, what’s gonna kill the infections for the body. Dr. Deb 11:38Right. David Jernigan 11:39Right? So it was a phenomenal way, but the LUAT test was amazing because what you’d do is you would give your treatment, like an MD would give an antibiotic for a week, ahead of time. Trying to increase the number of dead spirochetes showing up in your urine one day out of 3 days urine catch. So you’d wake up in the morning, you’d collect your urine 3 days in a row, and any one of those being positive is a positive. But it was a brilliant test because it wasn’t an antibody test. They were literally counting the number of dead pieces of Lyme bacteria in your urine. I mean, it was pretty irrefutable. So I had a grand slam on the… the Western blot on patients, and I’d also have a grand slam on the LUAT, and their medical doctors would say, oh, that doctor in the lab are probably in cahoots change some lab. Dr. Deb 12:38Of course. David Jernigan 12:39That come in. And I still see that today. You know, it’s like, oh my gosh, the better the tests are getting. There’s still a bias if you do your own research. Well, if you happen to be a doctor who loves research. And you’re a clinician, so you actually treat patients who’s gonna write the research study? Well, of course, the doctor who did the study, well, he’s biased, and I’m like, I still can’t influence lab tests. Well, lab tests aren’t everything. People scream over the internet at me. It’s like, well, a negative lab test doesn’t mean anything. I was like… I get that with the old Western blot testing. Dr. Deb 13:16Right. David Jernigan 13:16The more sensitive tests, which are very close to 100%, Sensitivity, and 100% specificity. So, meaning, like, they can… if you have the infection, they’re gonna find it. Dr. Deb 13:30They’ll find it, yeah. David Jernigan 13:31And if they… if you have the infection, they’re going to be able to tell you exactly 100% correctly what kind of infection it is. Back in those days, you couldn’t, you could just count the dead pieces, which was… Dr. Deb 13:43Yeah. David Jernigan 13:43Significant, but It’s funny, because when medicine does that, you know, mainstream medicine that’s backed by all the nice foundations who donate millions of dollars towards the research. Their negative tests are significant, but if you fund your own, Yours isn’t that significant. Dr. Deb 14:04Right, or what if we call something a seronegative autoimmune disease, like lupus or rheumatoid arthritis, because none of the tests are positive, but you have all the symptoms. Here, let me give you this $100,000 a year drug. David Jernigan 14:19Yeah. Dr. Deb 14:19And instead of looking for what might actually be causing the symptoms. That’s all okay, but what we do is not okay. David Jernigan 14:27Right. Yeah, it’s a double standard, and it’s getting better. I want to do… tell the world it is getting better. Some of the dinosaurs are retiring. Dr. Deb 14:36No. David Jernigan 14:37Way for people who are… Are more open-minded to new ideas. But, getting back to that woman, she… that formula that I made just for her and her son, I… She went online. Dr. Deb 14:54Which, I had never been on a news group. David Jernigan 14:58Not even sure I knew what one was, you know? Imagine, I’m kind of that dinosaur that… Cell phones were, like, these really big things with a big antenna sticking out of it, and… Dr. Deb 15:09Nope. David Jernigan 15:10So I thought I was pretty hot stuff, just that I actually had a computer software program that was running my front desk. And even then, it was an Apple IIe computer. Dr. Deb 15:21Right. David Jernigan 15:22Probably be pretty valuable right now if I’d kept it, but… Dr. Deb 15:25Mmm… David Jernigan 15:26It being an antique. But, suddenly people were calling my clinic, because the lady with the twin boys that was well was telling people on these research, I mean, these Lyme disease forums and boards online. And, I started going, oh my gosh, you know, as a doctor, it’s one thing to treat a person in your clinic, it’s a different thing to have your clinic name on the label. Like, we all do, Even now, and you’re supposed to write everything that’s on the label, and… all these guidelines, and I’m like, wow, I need to split this off. I mean, I def… I definitely want to help people, and this is… I was pretty excited about the results we were getting. Pre-treat… Pre-treatment and post-treatment. And, so… that’s where I developed, my nutraceutical business in the 90s called Journey Good Nutraceuticals. My advice to anybody thinking about doing the same thing, don’t put your last name on it. Dr. Deb 16:25– David Jernigan 16:25You know, because anytime negative anything comes out, there goes the Jernigan name, you know, the herbal, you know, there’s just all these, and especially nowadays, with all the bots that are just designed to slam natural medicine. Dr. Deb 16:38Yeah. David Jernigan 16:39And that is out there in a… and just ugly people. Dr. Deb 16:42Or should we just say, people with a different opinion? How’s that? David Jernigan 16:46Yeah. That are being less than supportive. Dr. Deb 16:49But. David Jernigan 16:51It was amazing, because by 1999, I presented my research, my first research, I’d never done research. This is what I would… I would say to a lot of people who go, my doctor did… I don’t know, my doctor doesn’t know what you’re doing, my doctor… I was like going, you know, most doctors don’t do research. They don’t publish anything. Their opinion is their opinion, but they don’t back it up in peer review, right? And so that’s what I always tried to do, was back it up in peer review and publish. And so, in 1999, I presented at the International Tick-Borne Diseases Conference in New York City. I’m telling you, it was like the country boy going to the city, you know, I got my… I got my suit on, and I looked all right, and my booth was wonderful, and all these different things, and it was just a big wake-up call.Because what we had demonstrated… let’s get back to the… and this was what I demonstrated with that first study. was that… A positive LUAC test, that Lyme urine antigen test for my Gen X, was a score of 32. Meaning, one of those 3 mornings urine had 32 pieces in the amount of urine they checked of deadline bacteria spirochetes. Okay? Okay. With antibiotic challenges, a highly positive was a score of 45. Dr. Deb 18:19Wow when I would give one dropper 3 times a day for a week. David Jernigan 18:24Ahead of time, and then do the person’s LUAT test, We were getting scores 100, 200… And at that point, we only had a couple, but we had a couple that were greater than 400. Yeah, dead pieces, where the lab just quits counting. They just said, somewhere over 400, right? Dr. Deb 18:45Yeah. David Jernigan 18:46Which, when the medical system at the conference, you know, I was the only natural doctor in the world that was… had any kind of proof of anything naturally that could outperform antibiotics. Can you imagine? Dr. Deb 18:59Yeah. And… David Jernigan 19:01They were just, oh my gosh, incredulous. They’re like, I’ve given the most… one guy came up to me, and to my face, and he goes, I’ve given the most aggressive antibiotic protocols And I’ve only seen one patient over 100. I was like, that makes this pretty significant, doesn’t it? But, it didn’t just, like, make us take off, because guess what? In Lyme world, if a pharmaceutical antibiotic made you feel horrible. That meant it was working. Dr. Deb 19:28That’s right. We used to, back in the day, if you didn’t herx. And had that horrible die-off reaction, for those of you who don’t know what a herx is, but if we didn’t make you herx, we weren’t doing our job right. David Jernigan 19:40You’re looking for your patients to feel horrible, and sometimes to the level of committing suicide. Dr. Deb 19:46Yes. David Jernigan 19:47So bad. Dr. Deb 19:48Yes. David Jernigan 19:49And I was the first doctor, I think, in the world to start screaming and hollering and saying, stop using the worsening of your patient’s symptoms as a guide to good treatment, because they’re… I wasn’t seeing it with my formulas. Because I was doing a comprehensive program of care. I think I was also one of the first doctors to say, we need to detoxify these people as we’re doing this. And you would sit there and say, well, sure you were. I was like, well, remember, there wasn’t a lot of communication. There wasn’t anybody on the internet saying, do this, do that. And, It was, it was interesting in those days. It was, how do you… How do you help the world heal from these things? That they don’t know they have. So later, I actually had a beautiful booth at a health… a big health expo in Texas, I remember, and I was like, you know, you spend a lot of money on the booth, and… Dr. Deb 20:43Yup. David Jernigan 20:43And you’re thinking about it because you’re funding the whole thing, you say, wow, if I only sell one case, I’ll at least cover my cost. Dr. Deb 20:51Yep. Yeah, you’re great. David Jernigan 20:52And I had this beautiful banner of, like, a blown-up tick’s mouth under microscope. You know those beautiful pictures of, like, all the barbs sticking out, and how they anchor themselves in your skin, and… And, thousand people walking by my booth, and they’re just like, keep walking, because they didn’t know they had Lyme. There was, like, and they had MS, maybe, but they don’t have Lyme, and so they just would keep walking. Nobody even knew. Why would I go to a conference in Texas? And I’m trying to say, no, guys, it’s everywhere. Dr. Deb 21:24Yeah. David Jernigan 21:24And… and everybody, you know, yes, you probably have this, you know, kind of thing. If you’re… if you… are chronically ill, almost, of any kind of way. You know, kind of trying to tell people this was… Again, in Robin’s pathology textbooks, one of the few things that it did tell you about Lyme was that it was called the Great… the New Great Imitator. Because it would imitate up to 200 or more different illnesses. So, it’s been an interesting journey, of… educating people, writing articles, but it was interesting, the lady who I first fixed, Laboratory verified, everything like that, symptoms went away, all that kind of fun stuff. Her children were fine, they’ve been fine for years now. When she went on the newsboards in the Lyme disease support groups, It created a war. Oh my goodness, it was like, how dare you? And, say that something natural might actually help, right? Dr. Deb 22:30Right, exactly. David Jernigan 22:32And, I even had… A… one of those first calls to… with a marketing company at one point, way a long time ago. And the lady got on the phone, the owner of the marketing company goes, I would have blood on my hands if I actually took your clinic on. Yeah, you can’t treat Lyme disease, and… Even the big, big associations that are out there are still largely that way. I mean, they’re getting better, but it’s just like… you know, a lot of the times, it’s herbs are good. Herbs will help. Good, you know, but they’re safe. So, it’s still a challenge to… to… present in mainstream Lyme communities, even. Because there’s this… Fear of doing anything outside of antibiotics. Dr. Deb 23:32Yeah, so let me ask you this. From your perspective. Why do you think so many chronic infections exist these days, like Lyme and the co-infections, Babesia, Bartonella, mold illness? And we talked a little bit about herbs and why they, antibiotics and things like that fail, but let’s talk a little bit about that. David Jernigan 23:53So, it’s fascinating. When I trained in Germany, they said that we, as humanity, has moved away from what they called the inflammatory diseases. You know, in the old days, it was. Lots of high fevers, purulent, pus-generating bacterial infections. And I said, as a society, we have… Dr. Deb 24:14Have shifted from those to what they call cold sclerotic diseases, which are your… David Jernigan 24:21Cancers, your diabetes, your atherosclerosis, your… and they said, we’re starting to see what used to only be geriatric diseases in our children. That’s how bad it’s gotten. We have suppressed fevers, we don’t… we don’t respect the wisdom of the human body. So, you know, the doctors say, step aside, body, I will fix this infection for you with this antibiotic. And so, what we’ve done with the, overuse of antibiotics, and this isn’t me just talking from a natural perspective, this is… Right, it’s everybody around the world is acknowledging. I’ll show you… I could show you a, a presentation, if we can do a screen-sharing situation. Yeah. About the antibiotic situation in the world, because it’s really concerning. But what I would say, and kind of like an advancement forward, is we are seeing mutated bacteria. You know, they talked about… do you remember when they found the Iceman, you know, the… You know, the prehistoric guy that’s… In the eyes, and he had Lyme bacteria. I was like, he had spirochetes, maybe. Dr. Deb 25:33Yeah. David Jernigan 25:33That isn’t a modified, mutated version. That’s just maybe the… Lyme… you know, Borrelia… call it Borrelia something, you know, it’s a spirochete, but what we’re dealing with today. Even under strep or staph, as you know, you know, Pseudomonas aeruginosa, you name it, whatever kind of infection a person has is not the same bacteria that your grandparents dealt with. Dr. Deb 26:01That’s right. David Jernigan 26:32It’s a much mutated, stronger, more resistant to treatment type of thing. So, I think that’s one reason. I think the, It’s great that we’re seeing, you know, Secretary Robert F. Kennedy Jr. bringing awareness to things that Like it or not, yeah, seed oils do create inflammation, and everyone in the natural realm, as you know. Has been trying to say this for probably how long? Dr. Deb 26:35Yeah, 25, 30 years. 20 years each. David Jernigan 26:48Yes. You know, thank goodness for people like Sally Fallon and her beautiful book, Nourishing Traditions, that started you know, Dr. Bernard Jensen’s books way back in the day, Dr. Christopher’s books way back in the day. Dr. Deb 26:48Damn. David Jernigan 26:49You know, all of them were way ahead of their time, saying, by the way, your margarine is only missing one ingredient from being axle grease. Dr. Deb 26:58Yeah. David Jernigan 26:58I think that was Dr. Jensen saying that at one point, probably 50, 60 years ago, I don’t know. Dr. Deb 27:03Yep. David Jernigan 27:04So, we’ve created this monster. We, we live in a very controlled environment, you know, of 72, 74 degrees at all times, we don’t sweat, we don’t have to work that hard, typically. You know, most of us aren’t out there like our ancestors were, so that’s making us more and more… Move towards the cold sclerotic diseases, of which even Lyme disease is, you know, which… Yes, it has inflammation, yes, but as a presentation, it’s very often associated with some of these Cold sclerotic diseases of mankind that we see now. Dr. Deb 27:46You have it. David Jernigan 27:47Yeah. Dr. Deb 27:48So, tell me, what is phage therapy? David Jernigan 27:52Well, may I show you a cool video? Dr. Deb 27:55Yeah, I’d love that. David Jernigan 27:56I did not make this video, this is just one of my favorites, because it’s from the National Institute of Health. Let’s see if I can just… Click the share screen thing. And get that to pop up. That’s not what I’m looking for, but it’s gonna be soon. Let’s go here… Alright, can you see that? Dr. Deb 28:18Yeah. David Jernigan 28:19Okay. Modern medicine faces a serious problem. Thanks in part to overuse and misuse of antibiotics, many bacteria are gaining resistance to our most common cures. Researchers are probing possible alternatives to antibiotics, including phages. So, bacteriophages, or we like to call them phages for short, are naturally occurring viruses that infect and kill bacteria. The basic structure consists of a head, a sheath, and tail fibers. The tail fibers are what mediate attachment to the bacterial cell. The DNA stored in the head will then travel down the sheath and be injected inside the cell. Once inside the cell, the phage will hijack the cellular machinery to make many copies of itself. Lastly, the newly assembled phages burst forth from the bacterium, which resets their phage life cycle and kills the bacterium in the process. Someday, healthcare providers may be able to treat MRSA and other stubborn bacterial infections using a mixture of phages, or a phage cocktail process would be first to identify what the pathogen is that’s causing the infection. So the bacterium is isolated and is characterized. And then there’s a need to select a phage in a process known as screening of phage that are either present in a repository or in a so-called phage library. That allows for many of the phages to be evaluated for effectiveness against that isolated I don’t know, bacterium. Phages were first discovered over 100 years ago by a French-Canadian named Felice Derrell. They initially gained popularity in Eastern Europe, however, Western countries largely abandoned phages in favor of antibiotics, which were better understood and easier to produce in large quantities. Now, with bacteria like these gaining resistance to antibiotics, phage research is gaining momentum in the United States once again. NIAID recently partnered with other government agencies to host a phage workshop, where researchers from NIH, FTA, the commercial sector, and academia gathered to discuss recent progress. NIH… So… That is… That is what phage therapy in… is. in what I call conventional phage. Let’s see, how do I get out of the share screen? Hope you already don’t see it. Dr. Deb 30:58Yep, at the top, there should just be a button. David Jernigan 31:00I don’t. Dr. Deb 31:00Stop sharing, yeah. David Jernigan 31:01So… Conventional phage therapy, as you just saw, is a lot like what it is that we’re doing, only the difference is they’re taking wild phages from the environment. They’re finding phages anywhere there’s, like, a lot of bacteria. And then they isolate those phages, and like he said, the gentleman at the very end said we put them in a library, and so there are banks of phages that they can actually now use, and One of the largest banks that I know of has about 700 different bacteriophages, or phages. In their bank that they can pull from. Dr. Deb 31:43Wow. Do you want to take a guess? David Jernigan 31:46How many bacteriophages they’ve identified are in the human gut, on average? Dr. Deb 31:52Oh my god, there’s gotta be more… David Jernigan 31:53Kinds, different kinds of phages, how many? Dr. Deb 31:56There’s gotta be millions. David Jernigan 31:57Well… In population, there’s… humongous numbers, numbers probably well beyond the trillions, okay? Hundreds of trillions, quadrillions, maybe, even. But in the gut, a recent peer-reviewed journal article said that there were 32,242 different types of bacteriophages that live naturally in your intestines, your gut. Dr. Deb 32:25Boom. David Jernigan 32:2632,000. Okay, so… If you read any article on phage therapy that’s in peer review, almost every single one in the very first paragraph, they use the same sentence. They go, Phages are ubiquitous in nature. They’re ubiquitous in nature. So my brain, when I find… when all this finally clicked together, and when we clicked together 5 years into my research, I could not get it to work for 5 years. I just kept going. But that sentence really got me going. I was, like, going, you know. If you look at what ubiquitous means, it says if Phages were the size of grains of sand. Like sand on the beach. They would completely cover the earth and be 50 miles deep. How crazy is that? Dr. Deb 33:24Wow. David Jernigan 33:25That’s how many phages are on the planet. There’s so many… they outnumber every species collectively on the planet. So, it’s an impossibility in my mind. I went, huh, it’s an impossibility that… You catching a, a sterile Bacteria, it’s almost an impossibility. Since the beginning of time, phages have been needing to use a reproductive host. And it’s very specific, so every kind of bacteria has its own kind of phage it uses as a reproductive host. Because phages are… and this is a clarification I want to make for people. just like in the old days, we were talking about the 90s, I talked to a veterinarian that had gotten in trouble with the veterinary board in her state. Dr. Deb 34:14Back in the old days. David Jernigan 34:16Because she gave dogs probiotics. And the board thought she was giving the dogs an infection so that she could treat them and make money off of the subsequent infection. Dr. Deb 34:28Oh my god. David Jernigan 34:29Nobody actually had heard of good, friendly bacteria in the veterinary world, I guess she said she had gotten in trouble, and she had to defend herself, that, no, I’m giving friendly, benevolent, beneficial bacteria. Okay, to these animals, and getting good results.So, phages… Are friendly, benevolent, beneficial viruses. That live in your body, but they only will infect a certain type of bacteria. So… What that means is if you have staff.Aureus, you know, Staphylococcus aureus bacteria. That bacteria has its own kind of phage that infects it called a staph aureus phage. E. coli has an E. coli phage. Each type of E. coli has its own phage, so Borrelia burgdurferi has its own Borrelia burgdurferi type of phage, whereas Borrelia miyamotoi alright? Or any of the other Borrelia species, or the Bartonella species, or the… you just keep going, and Moses has its own type of phage that only will infect that type of bacteria. So that’s… You know, when you realize, wow, why are we going to the environment Was my thought. Dr. Deb 35:54Yeah. David Jernigan 34:55Trying to find wild phages and put them into your body, and hopefully they go and do what you want them to do. What if we could trigger the phages themselves that live in your body to, instead of just farming that bacteria that it uses as a host, because what I mean by farming is the phages will only kill 40% of that population of bacteria a day. Dr. Deb 36:20Wow. David Jernigan 36:20And then they send out a signal to all the other phages saying, stop killing! Dr. Deb 36:24It’s like. David Jernigan 36:2560% of the bacteria population left to be breeding stock. It’s kind of like the farmer, the rancher, who… he doesn’t send his whole herd to the butcher. Dr. Deb 36:35Right. David Jernigan 36:36Just to, you know, he keeps his breeding stock. He sends the rest, right? So, the phages will kill 40% of the population every day, just in their reproduction process. Because once there’s so many, as you saw in the video, once the phage lands on top of the bacteria, injects its genetic material into the bacteria, that bacteria genetic engine starts cranking out up to 5,200 phages per bacteria. Dr. Deb 37:06I don’t know who counted all those… David Jernigan 37:08Inside of a bacteria, but some scientists peer-reviewed it and put it out there. that ruptures, and it literally looks like a grenade goes off inside of the bacteria. I wish I’d remembered to bring that video of a phage killing a bacteria, but it just goes, oof. And it’s just a cloud of dust. So, you’re breaking apart a lot of those different toxins and things. So… That’s… That was the impetus to me creating what I did. That and the fact that I looked it up, and I found out that phages will sometimes go… Crazy. I don’t know how to say it. Wiping out 100% of their host. And it could be a trigger, like change in the body’s pH levels, it could be electromagnetically done, you know, like, there’s been documentation of… I think it was, 50 Hz, electricity. Triggering one kind of phage to go… Crazy and annihilate its host population. There’s other ways, but I was, like, going, none of those fit me, you know? It’s not like I’m gonna shock somebody with a… Jumper cable or something to try to get phages to… to do that kind of thing. But the fact that it could be done, they can be triggered, they can switch and suddenly go crazy against their population. But what happens when they kill 100% of their host? The phages themselves die within 4 days. Dr. Deb 38:45Hmm. Because they can’t keep reproducing. David Jernigan 38:47There’s nothing to reproduce them, yeah. Dr. Deb 38:49Yeah. Especially… unless they’re a polyvalent phage, that means a phage that can segue and use. David Jernigan 38:54One or two other kinds of bacteria. To, as a reproductive host. But a lot of phages, if not the majority, are monovalent, which means they have one host that they like to use. And so… Borrelia, so… my study that I ended up doing, and I published the results in 2021, And it’s a small study, but it’s right in there at the high end, believe it or not, of phage research. Most phage research is less than 30 people. In the study. But, we did 26 people.And after one month of doing the phage induction that I invented, which only… Appears to only, induce or stimulate the types of phages that will do the job in your body. I don’t care what kind of phage it is. I don’t care if it’s a Borrelia phage, it may be a polyvalent phage that normally doesn’t use the Borrelia burgdurferi as its number one. Host, but it can. To go and kill that infection. And the fascinating thing is, there was a brand new test that came out at the same time I came out with the idea, literally the same weekend they presented. Dr. Deb 40:1511. David Jernigan 40:15ILADS conference in Boston in 2019. It was called the Felix Borrelia phage Test. So the Felix Borrelia phage test. Because Borrelia are often intracellular, right, they’re buried down in the tissue, they’re not often in the blood that much. And therefore, doing a blood test isn’t really that accurate. But you remember how there’s, like, potentially as many as 5,200 phages of that type erupt from each bacteria when it breaks apart. It’s way easier to detect those phages, because they’re now circulating, those 52, as you saw in the video. 5,200 different phages are now seeking out another Borrelia that they can infect. And so, while they’re out in circulation, that’s easy to find in the bloodstream. So, 77% of the people, so 20 out of 26, were tested after a 2-week period. After only a 4-day round of treatment. Because according to my testing, remember, I can actually test adjunctively to see if I can find any signatures for those kinds of bacteria. And I couldn’t after 4 days, so we discontinued treatment and waited Beyond the 4 days that would allow the phages themselves to die, so we waited about a week and a half.And redid the test. And 77%, so that 20 out of 26 of the people, were completely negative. Dr. Deb 41:50Wow. David Jernigan 41:52Which, you go, well, it’s just a blood test. Well, no, we actually had people that were getting better, like, they’d never gotten better before. We had one woman who was wheelchair-bound, and in two weeks was able to walk, and even ultimately wanted to work for my clinic. I’m just, like, going… Dr. Deb 42:07I didn’t want to write about all that. I wanted to write about the phages. I was like… David Jernigan 42:12article, I probably should have put some of those stories, because, Critics would say, well, you got rid of the infection, maybe, but… Did you fix the Lyme disease? Well, that’s… there’s two factors here that every doctor needs to understand. There’s the infection in chronic illness, there’s the infection, and then there’s the damage that’s been done. Because sometimes I have these people that would come in and say, well, Dr. Jernigan, it didn’t work for me, I’m still in the wheelchair. And I’m like, no, it worked. Repeat lab test over months says it’s gone, it’s gone, it’s gone. It’s like, we would follow, and 88% of the people we followed long-term were still negative, which is amazing to me. Dr. Deb 42:56And then they have to repair the damage. David Jernigan 42:59It’s the damages why you still have your symptoms. And that’s where the doctor has to get busy, right? Dr. Deb 43:06Right David Jernigan 43:06They were told erroneously by their doctor that originally treated them that they’d be well, they’d get out of the wheelchair, if he could actually kill all these infections. Dr. Deb 43:15It’s not true. David Jernigan 43:16Unless it’s caught early. So I love the analogy, and I’ve said it a thousand times.that Lyme disease and chronic infections are much like having termites in the wood of your house. If you find the termites early, then yeah, killing the infection, life goes back to normal, the storm comes and your house doesn’t fall down. But if it’s 20 years later. Killing the termites is still a grand idea. Right. But you have the damage in the wood that needs to be repaired as well. All the systems… when I talk about damage to the wood, I mean, like. All the bioregulatory aspects of the body, how it regulates itself, all the biochemical pathways, the metabolic pathways we all know about, getting the toxins that have been lodged in there for many years, stopping the inflammatory things that have been running crazy. Dealing with all those cytokines that are just running rampant through the body, creating this whole MCAS situation. Which are largely… Dr. Deb 44:21Coming from your body’s own immune cells called macrophages, which are not even… David Jernigan 44:26It’s not… a virus at all, it’s part of the immune system, it’s like a Pac-Man, and research shows that especially in spirochetes. There is no toxin. Now, I wrote 4 books. I think I wrote the very first book on the natural treatment of people with Lyme disease back in the 90s. Why did I write that? Not because I wanted to be famous, it’s a tiny book, actually, the first one was.I was just trying to help people get out of this idea that you will be well when you kill all the bugs. I was saying, it’s… you need to be doing this. If you can’t come to my clinic, at least do this. Try to find somebody that will do this for you. And that ultimately led to a bigger book.as I kept learning more, and I was like, going, well, okay, now at least do this amount of stuff. And you need to make sure your doctor is handling this, this, this, and this. And so, the third book was, like, 500 and something pages long. And then the fourth book was 500 and something pages long, and now they’re all obsolete with the whole phage thing, because this just rewrites everything. Dr. Deb 45:34Yeah. David Jernigan 45:34It’s pretty fascinating. Dr. Deb 45:37Do you think the war on bugs, mentality created more chronic illness than it solved? David Jernigan 45:44Because of the tools that doctors had to use, yes. We’re a minority, we’re still a minority, you and I. Dr. Deb 45:54Yep. Our doctoring… David Jernigan 45:56Methods I never had, and you’d never… maybe you did, but I’d never had the ability to grab a prescription pad and write out a prescription. I had to figure out, how do I get… and this was… and still my guiding thing, is like, how do I identify, number one, everything that can be found that’s gone wrong in the human body. And what do I need to provide that body? Like, the body is the carpenter. That has to do the repair, has to regenerate, has to do everything, has to get… everything fixed right? We can’t fix anything. If you have a paper cut, there isn’t a doctor on the planet that can make that go away. Dr. Deb 46:38Right. David Jernigan 46:39Of their own power, much less chronic illnesses. So, all the treatments are like the screws, saws, hammers, you know the carpenter must be able to use. So a lot of the time, doctors are just throwing an entire Home Depot on top of the carpenter. In the form of, like, bags of supplements, you know, hundreds of supplements, I’ve seen patients walk in my door with two suitcasefuls. And they were taking 70 bottles, 65 to 70 bottles of supplements, and I’d be just like, wow, your carpenter who’s been working for 24 hours a day, 7 days a week. He’s exhausted. There’s chaos everywhere, you don’t know where to. Dr. Deb 47:22Starting. David Jernigan 47:22He goes, you want me to do what with all this stuff? Dr. Deb 47:25Yep, I’ve seen the same thing. People… thousands, you know, several thousand dollars a month on supplements, and not any better. But they’re afraid to give up their supplements, too, because they don’t want to go backwards, either, and… there’s got to be a better way on both sides, the conventional side and the alternative side, although you and I don’t say it’s alternative, that’s the way medicine should be, but… David Jernigan 47:48Right. Dr. Deb 47:49We have to have a good balance on both sides. David Jernigan 47:52And I will say, too, in defense of doctors using a lot of supplements, I do use a lot of supplements. Dr. Deb 47:57Yeah, I do too. David Jernigan 47:58but I want to synergize what I’m giving the patient so that the carpenter isn’t overwhelmed and can actually get the job done. Like, everything has to work harmoniously together, so it’s not that… It’s not the number of supplements, and why would you need a lot of supplements? Well, because every system in your body is Messed up. My kind of clientele for 30 years. Our clientele, yours and mine. Dr. Deb 48:25Yeah. David Jernigan 48:26They have been sick, For decades, many of them. Dr. Deb 48:31Yeah. David Jernigan 48:31And if they went into a hospital, they honestly need every department. They need endocrinology, they need their kidney doctor, they need their… They’re a cardiologists, they need a neurologist, they need a rheumatologist. I mean, because none of those doctors are gonna deal with everything. They’re just gonna deal with one piece of the puzzle. And if they did get the benefit of all the different departments they need, yeah, they’d go out with a garbage bag full of stuff, too. Dr. Deb 48:57Hey, wood. David Jernigan 48:58Only, they’re not synergized. They don’t work together. You’re creating this chemistry set of who knows how much poison. And I want to tell your listeners, and I mean, you probably say this to your patients as well. There is a law of pharmacy that I learned eons ago, and it applies to natural medicine, too. Dr. Deb 49:21Yep. David Jernigan 49:22But the law says every drug’s primary side effect Is its primary action. So, if you listen to TV, you can see this on commercials. I love… I love listening to these commercials, because I’m like, wow. let’s… let’s… I don’t want to say I’ve named Brandon. I don’t know if that’s…Inappropriate to name a name brand, but let’s just say you have a pharmaceutical that is for sleep. After they show you this beautiful scene of the person restfully sleeping and everything like that, they tell you the truth. It’s like, this may cause sleepiness… I mean, sleeplessness. Dr. Deb 50:04Yeah. David Jernigan 50:04Found insomnia. Dr. Deb 50:06And headaches, and diarrhea. David Jernigan 50:08All the other things, and if it’s an antidepressant, what does the commercial do after it finishes showing you little bunny foo-foo, jumping through a green, happy people? They tell you, this may create depression, severe depression, and suicidal tendencies, which is the ultimate depression. So, I want everyone to understand you need to figure out what your doctor’s tools are that they’re asking you to take, and they’re wanting you to take it forever, generally in mainstream medicine, right? In the hospitals and everything. They don’t say, hey, your heart has this condition, take this medicine for 3 months, after which time you can get off. Dr. Deb 50:48Yep. David Jernigan 50:49not fixing it, right? So… That, on a timeline, there is a point, if it was truly even fixing anything. That you… it’s done what it should do, and you should get off, even if it’s a natural product. It’s just like. Dr. Deb 51:03Right David Jernigan 51:03It’s done what it should do, and you should get off, but instead. you go through the tree… the correction and out the other side, and that’s where it starts manifesting a lot of the same problems that it had. So, anti-inflammatories, painkillers, imagine the number one side effects are pain inflammation. So, the doctor says, well. If you say, hey, I’m having more pain, what does he do? He ups the dosage. And if he… if that doesn’t work, if you’re still in a lot of pain, which he would be, he changes it to a more powerful thing, right? But it starts the cycle all over again. So when you ask me, it’s like, why are we having so much chronic illness? It’s because of the whole philosophy. is the treatment philosophy of mainstream medicine that despises what you and I do. Because we’re… our philosophy from the start is the biggest thing. It’s like… We’re striving for cure. That dirty four-letter word, cure, we’re not even supposed to use it. And yet, if you look it up in Stedman’s Medical Dictionary, it just means a restoration of health. Remission. Everyone’s like, oh, I’m in remission. I’m like, remission is a drug term. It’s a medical term. Again, look it up in a medical dictionary. It is a pharmaceutical term for a temporary pause Or a reduction of your symptom, but because it’s just… symptom suppression, it will come back. It’s… remission is great, I suppose, in… At the end of, like, where you’ve exhausted everything, because I can’t fix everything, I don’t know about you. Dr. Deb 52:41No, I can’t either, yeah. David Jernigan 52:43you know, on my phone consults, I try to always remind people, as much as I get excited about my technologies gosh, I see so much opportunity to fix you. I always try to go, please understand, I’m gonna tell you what most doctors may not tell you on a phone consultation. I can’t fix everything. Dr. Deb 53:03Yeah. David Jernigan 53:03For all of my tricks, I can’t fix everything. Not tricks, but you know, all my technologies, and all my inventions. Phages, too. They are a tool. You know, antibiotics. I think I wrote a blog one time, it should be on my website somewhere, that says, Antibiotics do not… fix… neurological disease, or… I don’t know, something like that. You know, you’re using the wrong tool. I mean, it does what it does. Dr. Deb 53:32Yeah, you’re using a hammer to do what a screwdriver needs to. David Jernigan 53:35Yeah, you know, it’s like it’s… And yet, you can probably tell her… that you’ve had patients, too, that they go, Dr. Jernigan. My throat was so sore, and as soon as I swallowed that antibiotic. I felt better, and I’m, like, going… How long did it take? Oh, it was immediate! I was like, dude, the gel cap didn’t even have time to dissolve, I mean… Dr. Deb 53:58SIBO. David Jernigan 54:00But, it’s not going to repair the tissues that were all raw. kind of stuff. So, I mean, that ulceration of your throat that’s happening, the inflammation, there’s no anti-inflammatory effect of these things. So, I digress a little bit, but phages, too… I wrote an article that’s on the website, that’s setting healthy expectations for phages, because they want… we can see some amazing things happen, things that in my 30 years, I wish I had all my career to do over again, now having this tool. It’s just that much fun. I… when doctors around the country now are starting to use our inducent formulas, there’s, 13 of them now, formulas. For different broad-spectrum illness presentations. I tell them all the same thing, I was like, you are gonna have so much fun. Dr. Deb 54:53That’s exciting. Women. David Jernigan 54:54Winning is fun, you know? I was like. You know, mainstream medicine may never accept this, I don’t know. I feel a real huge burden, though, to do my best to follow a, very scientific methodology. I’ve published as much as I can publish at this time by myself. I never took money from the… the sources that are out there, because what do they do? They always come… money comes with strings. Dr. Deb 55:22Yes, it does. David Jernigan 55:23I don’t trust… I don’t trust… I mean, if you listen to the, roundtable that Our Secretary Robert F. Kennedy Jr. Dr. Deb 55:35Yeah. David Jernigan 55:36On Lyme disease last week the first couple of speakers were, like, pretty legit. I mean, all of them were legit, but I mean, they were, like, senators and congressmen or something like that, I think. And then you have… RFK Jr. himself, who’s legit. Yeah they were fessing up to the fact that, yes, they were suppressing anything to do with Lyme. Dr. Deb 56:00Yeah. David Jernigan 56:00Our… our highest levels of, marbled halls and pillars and… of medicine were doing everything the way I thought they were. They were suppressing me. I was like, how can you ignore the best formulas ever, and still, I think Borreligen, and now, induced native phage therapy are still, I believe, I don’t… I’ve never seen it, I could be wrong. The only natural things that have been documented in a medical methodology. Dr. Deb 56:34Hmm in the natural realm. I mean, all the herbs that we talk about. David Jernigan 56:39You know, there’s one that was really famous for a while, and it said, we gave… so many patients. This product, and other nutritional supplements. And at the end, X number of them were… dramatically better. That’s not research. Dr. Deb 56:57Right. That’s observation. David Jernigan 56:59The trick there was we gave this one thing, and then we gave high-dose proteolytic enzymes, we gave high dose this, we gave high dose that, but at the end of the study, we’re going to point back at the thing we’re trying to sell you as being what did it. Dr. Deb 57:12Which is what we do in all research, pretty much. David Jernigan 57:15Well… Dr. Deb 57:16tried to… David Jernigan 57:17Good guys, I hope. Dr. Deb 57:18Do the way we want, right? In… in conventional… David Jernigan 57:22Yeah. Dr. Deb 57:22Fantastic David Jernigan 57:23Very often, yeah, in conventional medicine, definitely. Yeah. And, it’s kind of scary, isn’t it, how many pharmaceuticals are slamming us with, because they’re… Dr. Deb 57:33Okay. David Jernigan 57:34There’s a new one on TV every day, and there’s. Dr. Deb 57:36Every day, yes. David Jernigan 57:37It’s like, who comes up with these names? They’re just horrible. Dr. Deb 57:40Yeah, you can’t pronounce them. David Jernigan 57:41I want to be a marketing company and come up with some Zimbabwehika, or something that actually they go with, and I’m like, I just made a million bucks coming up with it. I’ll be glad when that’s not on the TV anymore, which… Oh, me too. Me too. Dr. Deb 57:54Dr. Jaredgen, this was really wonderful. What do you want to leave our listeners with? David Jernigan 58:00Well, you know, everyone’s calling for a new treatment. Dr. Deb 58:05Yeah. You bet. David Jernigan 58:08I have done everything I can do to get it out there, scientifically, in peer review, so that if you want to look up my name. Dr. Deb 58:16I published an open access journal so that you didn’t have to buy the articles. Like, PubMed, you have to be a member. If you want to look at a lot of the research, you have to buy the articles. David Jernigan 58:26I’ve done everything open access so that people had access to the information. I honestly created induced native phage therapy to fix my own wife. I mean, I… I was… I used to think I could actually fix almost anything. Gave me enough time. And, I could not fix her. You know, the first 10 years, she was bedridden. Dr. Deb 58:49Wow. David Jernigan 58:50People go, oh, it’s easy for you, Dr. Jernigan, you’re a doctor. Dr. Deb 58:54Oh yeah, right? Yeah. David Jernigan 58:56Oh my gosh, how many tears have been shed, and how much heartache, and how much of this and that. I mean, 90% of our marriage, she was in, bed, just missing Christmas. All the horror stories you hear in the Lime world, that was her, and I could not get her completely well. And, she’s a very discerning woman. I say that in all my podcasts, because it’s. Dr. Deb 59:19Just… David Jernigan 59:16Amazing. It’s like, every husband, I think, should want a wife that’s… Always, right? Not that you surrender your own opinion, but it’s like, it’s… it was literally, I don’t know what, 6 months before the ILADS conference in Boston in 2029… in 2019 that She said, are you going to the ILADS conference this year? And I’m like, I’ve been going for, like, 15, 20 years, however long it’s been going on, and I was like, I’m not gonna go to this one. And, 3 days before the conference, she says, I think you should go. And I go, okay. Like I say, she’s generally right. And that… I bought a Scientific American magazine at the newsstand in the Nashville airport. Started reading a story about phages in that that copped that edition of the Scientific American, and It was a good article, but it wasn’t super meaty, you know. very deep on those, but I just was stimulated. Something about being at elevation. Dr. Deb 1:00:02Yeah. Your own mountains, I don’t know, I get all inspired. David Jernigan 1:00:25And I wrote in the margins and highlighted this and that until it was, like, ultimately, I spent the entire conference hammering this out. And it worked. And it’s been working, it’s just amazing. It’s… We’re over 200 different infections that we’ve… we’ve clinically or laboratory-wise documented. There’s a new test for my GenX called the CEPCR Lyme Panel. like, culture. 64 different types of infections, and I believe right now the latest count is something like 10 for 10 were completely negative. Dr. Deb 1:01:03Wow. David Jernigan 1:01:03These chronically infected people. And so, that hadn’t been published anywhere. So, in my published article, remember I was talking about that 20 out of the 26 were tested as negative for the infection? That doesn’t mean they’re cured, okay? Remember, they’re chronically damaged. That’s how we need to look at it. Dr. Deb 1:01:23funny David Jernigan 1:01:24damaged. You’re not just chronically infected. And, but with 30-day treatment.24 out of the 26 were tested as negative. Dr. Deb Muth 1:01:34That’s amazing. David Jernigan 1:01:35So 92% of the people were negative.Okay? The chances of that happening, when you run it through statistical analysis.The chances… when you compare the results to the sensitivity percentages, you know, the 100% specificity and 92% sensitivity of the…Of the lab testIt’s a 4.5 nonillion to 1 chance that it was a fluke. Isn’t that amazing? Now, nearly… I’m not even sure how many zeros that is, but it’s a lot. Dr. Deb Muth 1:02:08That’s is awesome. David Jernigan 1:02:09Like, if I just said, well, it’s a one in a million chance it was a fluke.Okay.So, lab tests don’t lie. You’re not done, necessarily, just because you got rid of the infections. Now that formula for Lyme has grown to be 90-plusmicrobes targeted in the one formula. So, we figured out we can actually target individually, but collectively, almost like an antibiotic that’s laser-guided to only go after the bad guys that we targeted.So, all the Borrelia types are targeted, all the Babesias, for,the Bartonellas, the anaplasmosis, you name it, mycoplasma types are all targeted in that one formula, because I said.Took my collective 30 years of experience and 15,000 patients.that I would typically see as co-infections and put them into that one formula, so…When we get these tests coming back that are testing for 64, it’s because of that.So, there’s a lot of coolnesses that I could actually keep going and going. Dr. Deb Muth 1:03:15That’s exciting. David Jernigan 1:03:15I love this topic, but I thank you for letting me come on. Dr. Deb Muth 1:03:18Thank you for joining us. How can people find you? David Jernigan 1:03:22Two ways. There’s the Phagen Corp company that is now manufacturing my formulas.That is P-H-A-G-E-N-C-O-R-P dot com. Practitioners can go there, and there’s a practitioner side of the website that’s very beefy with science, and… and all the formulas that were used, what’s inside of all the formulas, meaning what microbes are targeted by each one. Like, there’s a GI formula, there’s a UTI formula, there’s a SIRS formula, there’s a Lyme formula, there’s a central nervous system type infection formula, there’s… And we can keep going, you know, SIBO, SIFO formula, mold formula… I mean, we’ve discovered so many things that I could just keep going for hours, and… Dr. Deb Muth 1:04:05Yeah. David Jernigan 1:04:06About the discoveries, from where it started in its humble beginnings, To now, so… There’s another way, if you wanted to see our clinic website, is Biologics, with an X, so B-I-O-L-O-G-I-X, Center, C-E-N-T-E-R dot com. And, if somebody thinks they want to be a patient and experience this at our clinic, typically we don’t take just Easy stuff. All we see is chronic.Chronic cases from all over the world. Something like 96% of our patients come from other states and countries. And typically, I’ve been close to 90% for my whole career.About 30-something percent come from other countries in that, so… we’ve gotten really good and learned a lot in having to deal with what nobody else knows what to do with. But if you do want to do that, you can contact us. And, if you… If you don’t get the answers from my patient care staff, then I do free consultations. With the people that are thinking about, whether we can help them or not. Dr. Deb Muth 1:05:13Well, that’s excellent. For those of you who are driving or don’t have any way of writing things down, don’t worry about it, we’ve got you. We will have all of his contact information in our show notes, so you will be able to reach out to him. Thank you again for joining me. This has been an amazing conversation. David Jernigan 1:05:30Thank you, I appreciate you having me on. It was a lot of fun. The post Episode 252 – Induced Native Phage Therapy (INPT) & advanced natural therapies first appeared on Let's Talk Wellness Now.
Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Come see and talk to Elvis and Barb at all these amazing shows coming up in 2026 * Vision 21 in Las Vegas Jan 15-17 https://www.nadl.org/nadl-vision-21 * Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ * LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday * Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ * exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week we sit down with Stuart Steinbock for a wide-ranging conversation that blends dental industry history, innovation, and personal resilience. As a fourth-generation member of the Steinbock family, Stuart shares the origin story of Whip Mix (https://whipmix.com/)—from an egg beater with patented features to a global dental manufacturer—and his own unlikely path into the family business, including international expansion, lean manufacturing, and product development that helped shape how labs think about efficiency and quality The conversation follows Stuart's journey beyond Whip Mix into startups, direct-to-consumer aligners, 3D printing with Carbon (https://www.carbon3d.com/), pandemic-era manufacturing, and running a high-volume orthodontic lab, before landing at Digital Dental (https://www.digitaldental.com/) as president. Along the way, Stuart offers candid insights on entrepreneurship, digital workflows, ortho vs. restorative mindsets, leadership through change, and the human side of the dental industry—ending with a powerful personal update on family, recovery, and finding balance after adversity Special Guest: Stuart Steinbock.
In this episode, Dr. Theodore Schurr shares insights from his career researching genetic prehistories, linkages, and identities within transforming geopolitical landscapes of the past as well as contemporary sociopolitical shifts, including post-Soviet Russia and Georgia. Next, Dr. Schurr and hosts Cara and Chris reflect on the evolution of anthropology and genetic research, including breakthrough technologies and advanced field methods, changing bioethics, intentional relationships with communities, and exciting new approaches that are expanding our understanding of variation and genetic-environmental interactions of the past and present. Dr. Theodore (Tad) Schurr is a Professor in the Department of Anthropology and the Director of the Laboratory of Molecular Anthropology at the University of Pennsylvania. For over thirty years, he has investigated the genetic prehistory of Asia and the Americas through studies of mtDNA, Y-chromosome, and autosomal DNA variation in Asian, Siberian, and Native American populations. For these studies, his lab characterized genetic diversity in indigenous populations of Canada, the United States, Mexico, and the Caribbean. His research group is currently exploring the population history of Georgia (Caucasus), Pakistan, Kazakhstan, and Polynesia through collaborative studies in those regions. Other projects have investigated the role of the mtDNA in adaptation, cancer, complex diseases, and metabolism. ------------------------------ Find the papers discussed in this episode: Yardumian, A., Shengelia, R., Chitanava, D., Laliashvili, S., Bitadze, L., Laliashvili, I., ... & Schurr, T. G. (2017). Genetic diversity in Svaneti and its implications for the human settlement of the Highland Caucasus. American journal of physical anthropology, 164(4), 837-852. Schurr, T. G., Shengelia, R., Shamoon-Pour, M., Chitanava, D., Laliashvili, S., Laliashvili, I., ... & Yardumian, A. (2023). Genetic analysis of Mingrelians reveals long-term continuity of populations in Western Georgia (Caucasus). Genome Biology and Evolution, 15(11), evad198. Ancient Lineages: Reconstructing the Genetic History of Svaneti, Northwest Georgia https://www.penn.museum/sites/expedition/ancient-lineages/ ------------------------------ Contact Dr. Schurr: tgschurr@sas.upenn.edu ------------------------------ Contact the Sausage of Science Podcast and the Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Co-Host Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Cara Ocobock, Co-Host Website: sites.nd.edu/cara-ocobock/, Email:cocobock@nd.edu, Twitter:@CaraOcobock Mecca Howe, SoS Co-Producer, HBA Fellow LinkedIn: https://www.linkedin.com/in/mecca-howe/, Email: howemecca@gmail.com
This week, we dive deep into the evolving world of digital dentures with George Cowburn, along with denturist Robert MacLeay and digital designer Kaylee Jilbert. George shares his unconventional path from engineering into dentures, the early challenges of bringing CAD/CAM into removables, and why his company Perfit has evolved into Lab Pilot (https://www.labpilot.net/)—a cloud-based approach designed to meet labs and denturists where they are, not where software companies wish they'd be. Robert and Kaylee bring the real-world perspective, explaining how combining analog fundamentals with digital design unlocked predictable, better-fitting dentures and titanium partial frameworks that actually snap into place. From monolithic milled partials to same-day digital relines and cloud-based CAM without subscriptions, this conversation explores how “trad-digital” workflows could finally make digital dentures accessible, scalable, and practical for everyday labs—without sacrificing fit, function, or sanity. Happy Holidays from Ivoclar! As the year comes to a close, all of us at Ivoclar want to extend our heartfelt gratitude to the incredible Voices From the Bench community. Thank you for your partnership, your trust, and the support you've shown throughout the year. From our Ivoclar family to yours, we wish you a joyful, healthy, and safe holiday season. May your days be merry, your nights be bright, and your smiles shine like freshly fallen snow. Ho, ho, ho — Happy Holidays from Ivoclar! Big news is coming your way in the world of CAM. Our friends at Ivoclar have teamed up with FOLLOW-ME! Technology (https://www.follow-me-tech.com/) to bring the Ivotion Denture System (https://www.ivoclar.com/en_us/products/digital-processes/ivotion) into the HyperDent CAM (https://www.follow-me-tech.com/hyperdent/) workflow. That's right—your favorite pre-shaded, two-layer Ivotion discs, the ones that let you design and mill a complete denture in one seamless process with no bonding and no mess, are now moving beyond closed systems. Thanks to this new partnership, Ivotion can finally be milled on open machines through HyperDent. And it gets better: you'll first see this powerful workflow available on the Roland DWX-53 series mills (https://www.rolanddga.com/products/dental/dwx-53d)—already a staple in so many labs—as well as the Imagine iMills (https://www.imagineusa.com/legacy/s/mills/imill). If you've been waiting for a faster, cleaner, more flexible way to produce full dentures, this is it. Ivoclar and FOLLOW-ME! just made the future of denture manufacturing wide open. Get ready—HyperDent is about to change the way you mill Ivotion. Special Guests: George Cowburn, Kaylee Jilbert , and Robert MacLeay .
A recent Osteoporosis International review summarized multiple studies showing that microplastics have been detected in human bone tissue, where they disrupt bone cell activity, trigger inflammation, and weaken structural integrity Laboratory and animal studies show microplastics accelerate osteoclast activity and alter bone microarchitecture, linking environmental plastic exposure to rising rates of bone fragility and dysplasia Microplastics are not limited to bone; previous research has also detected them in the bloodstream, brain, placenta, heart, lungs, liver, kidneys, and reproductive tissues Ultrafine combustion particles (UFPs), which are smaller than microplastics, pose an even greater threat due to the vastly higher levels of exposure you face each day Lower your daily microplastic exposure by switching to natural fabrics, filtering your air and water, avoiding plastic containers, and replacing plastic kitchen tools with safer materials
International Space Station leaders Laura Shaw and Jennifer Buchli discuss the science, discoveries, and innovations that have defined nearly 25 years aboard the orbiting laboratory. HWHAP 406.
1/4. The Genesis of the Asteroid Hunter Mission and Early Rejections — Dante Lauretta — Lauretta, hired by mentor Mike Drake at the Lunar and Planetary Laboratory (LPL), initiated the asteroid sample return mission concept in 2004 following a pivotal meeting with Lockheed Martin's Steve Price. The team submitted its initial proposal to NASA in July 2004, which received the agency's lowest competitive ranking, designated Category 4. A subsequent refined mission proposal targeting asteroid 1999 RQ36 was formally rejected in December 2007 due to prohibitively high estimated costs relative to the NASA planetary science program budget allocation. 1930
© 2020-2026 Ivy Podcast Discovery LLC
